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The cornerstone of successful tissue engineering rests upon a constructive interaction 
between cells and scaffolds. Stem cells have unique capabilities of self-renewal and 
multi-lineage differentiation to serve as a versatile cell source, while polyethylene 
glycol linked multi-walled carbon nanotubes (PEG-CNTs), with high conductivity, 
large surface-to-volume ratio, outstanding mechanical properties and nanotopographic 
features, have lately emerged as a promising candidate in producing scaffolds. This 
thesis, therefore, investigated the application of PEG-CNT-based scaffolds to modulate 
the differentiation of various stem cells into dedicated cell lineages for tissue 
engineering to address specific clinical needs.  
PEG-CNT films were prepared on cover slips with nanoscale surface roughness, 
orderly arrangement of PEG-CNTs, high hydrophilicity and high mechanical strength. 
The influence of PEG-CNT films to modulate skeletal myogenic differentiation of 
human mesenchymal stem cells (hMSCs) was explored. Notably, PEG-CNT films 
alone could direct the skeletal myogenic differentiation of hMSCs, even in the absence 
of myogenic induction factors. The quantitative real-time polymerase chain reaction 
(RT-PCR) showed that the non-induced hMSCs plated on PEG-CNT films, compared 
to the negative control, presented significant up-regulation of general myogenic 
markers including MyoD, desmin and MHC. Corresponding protein analysis by 
immunoblot assays corroborated these results. Skeletal muscle-specific markers, TnC 
and Ryr, were also found significantly increased in the non-induced hMSCs on PEG-
CNT films by RT-PCR. For these cells, the commitment to specific skeletal myoblasts 
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was further proved by the absence of enhanced adipogenic, chondrogenic and 
osteogenic markers. This study elucidated that PEG-CNT films supported a dedicated 
differentiation of hMSCs into a skeletal myogenic lineage. 
To enhance the myogenic differentiation of hMSCs, we designed and fabricated a PEG-
CNTs coated poly-acrylamide hydrogel with close stiffness to human muscle (CNT-
PA-M). hMSCs demonstrated efficient attachment and maintenance on the CNT-PA-M. 
Additionally, spontaneous myogenesis of hMSCs on CNT-PA-M was observed by 
immunostaining of MyoD, desmin and MHC, indicating that scaffold stiffness 
adjustment could be a key parameter to fine-tune, in order to optimize stem cell 
differentiation.  
As a result, PEG-CNTs coated poly-acrylamide hydrogel with calibrated stiffness that 
mimicked healthy human liver (CNT-PA-L) was prepared and examined for its effect 
on modulating differentiation of human amniotic epithelial cells (hAECs) into 
functional hepatocyte-like cells (HLCs). Firstly, the CNT-PA-L supported HLCs 
adhesion and growth, coaxing them to assume a hepatocytic polygonal morphology. 
Secondly, at the end of 18 days, the HLCs on CNT-PA-L lost pluripotent markers 
(Nodal, Nanog and OCT4) and up-regulated several hepatic markers (AFP, ALB, 
HNF4α, α1AT, CK18, G6P, CYP3A4, CYP2C9), some of which were even higher than 
that in HepG2 or HepaRG cells, through RT-PCR-based transcript analysis. Protein 
expression analysis by immunostaining substantiated these results. Furthermore, the 
HLCs on CNT-PA-L demonstrated functional capabilities of hepatocytes in terms of 
some ALB secretion, higher uptake of indocyanine green and comparable CYP3A4 
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enzymatic function and its inducibility as compared to HepG2 cells. Taken together, 
CNT-PA-L provides an efficient and scalable platform for the expansion of HLCs from 
hAECs. 
Collectively, these landmark findings led us to conclude that PEG-CNTs could be a 
highly versatile coating material to enhance the course of stem cell differentiation 
towards dedicated lineages under suitable conditions by using proper stem cells as 
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CHAPTER 1.  Introduction  
1.1  Tissue engineering 
Organ/tissue transplantation is often the only treatment for end stage organ/tissue 
failure, which cannot otherwise be adequately treated pharmacologically (1). In terms 
of organs, the kidneys are the most frequently transplanted organs, followed by the liver 
and then the heart. Diabetes, hypertension and inherited kidney diseases such as 
polycystic kidney disease are the most common causes of kidney failure requiring 
transplants (2). In addition, liver failure can be caused by viral infections, genetic 
disorders or even alcoholism. These conditions result in cirrhosis, which forms scar 
tissue that blocks blood flow and thus impedes essential liver functions in terms of 
detoxification, protein synthesis and digestive biochemical production. Liver 
transplantation is thus required when the liver failure severely impairs patients’ health 
and life quality (3). Moreover, a number of heart diseases, including coronary artery 
diseases, cardiomyopathy or heart muscle weakening, may render transplantation 
necessary (4). In the situation of tissue transplantation, cornea and musculoskeletal 
grafts are the most commonly transplanted tissues. A corneal graft can restore sight in 
corneal blindness; bone and tendon transplantation can be carried out to replace or 
reconstruct tissues destroyed by tumors, trauma or infection, thus saving limbs that 
would otherwise be amputated.  
Based on the source of the donor, the living organs/tissues transplantation can be 
divided into autografts (implants from patient to himself/herself) or allografts (implants 
from a donor). Both autografts and allografts require the removal of healthy 
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organ/tissue to replace the damaged parts, and therefore they are severely limited by 
crucial tissue shortage and can lead to donor-site morbidity, which further causes 
functional loss (5). Furthermore, allografts are often associated with an immune 
rejection and expose the patients to higher risk of viral infections.  
Artificial grafts such as man-made blood vessels and artificial joints have been 
developed and applied clinically (6, 7). However, they cannot recapitulate all the 
functions of real tissues and may not be able to undergo tissue repair, hence limiting 
their long-term viability (8). Moreover, adverse inflammatory and immune reactions 
or even direct toxicity provoked by an artificial implanted material can jeopardize their 
applications. For example, infections are common among patients with artificial joints 
(9); silicone breast implants could also cause a systemic inflammatory disorder in clinic 
(10).  
The need for improved treatments has motivated research on tissue engineering and 
has now emerged as a potential preference to organ/tissue transplantation. Tissue 
engineering is defined by Prof. Williams as “the creation or formation of new tissue for 
the therapeutic reconstruction of the human body, by the deliberate and controlled 
stimulation of selected target cells through a systematic combination of molecular and 
mechanical signals” (11). For therapeutic applications, the engineered tissue is either 
grown in patients (e.g., chondrocytes embedded in a matrix to form the expected 
functional cartilage tissue) or outside the patients and transplanted subsequently (e.g., 
fully functional liver tissue). This tissue technology could regenerate patients’ tissues 
or organs that are biocompatible, biofunctional, immunologically compatible and 
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easily available. In addition to these attributes, tissue engineering may provide a stable 
resource of tissue for in vitro applications, such as pharmaceutical testing (e.g., uptake, 
metabolism and toxicity of drugs), investigating the pathogenicity of diseases, 
industrial production of insulin by bioartificial pancreas, generation of blood cells to 
reduce the need for blood donors etc. (12).  
To regenerate new tissues, the two most essential components are cells and scaffolds. 
The cells, which may be a part of an engineered tissue [e.g., human mesenchymal stem 
cells (hMSCs) encapsulated inside a hydrogel matrix for muscle tissue engineering in 
vitro (13)] or recruited in vivo with the help of scaffolds [poly-L-lactic acid 
(PLLA)/demineralized bone powders (DBPs) scaffolds alone repaired rat skull defects 
in vivo (14)], constitute the “prototype” of the living tissue to generate and to synthesize 
matrices for repopulation; the scaffolds provide an appropriate environment to facilitate 
intercellular contact and signaling, and consequently enable the cells to effectively 
engraft into host tissues and recapitulate endogenous functions. In some cases, cells 
and scaffolds could collaborate with differentiation inducing factors, such as 
proteinaceous growth factors and chemical inducers, which function as “switches” for 
facilitating and committing the cells to differentiate into the respective cell lineages 
and attain the fully functionalized new tissue (15). 
 
1.2  Stem cells in tissue engineering 
Although several tissues are important sources of therapeutically relevant differentiated 
cells, the inevitable problems are the difficulty in harvesting sufficient cells for 
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implantation. Lineages such as neurons and cardiac cells, being terminally 
differentiated and non-regenerative, impose the biggest challenge. In this light, 
pluripotent stem cells have attracted much attention due to their unique capabilities of 
self-renewal in an undifferentiated state for prolonged duration and multi-lineage 
differentiation with proper stimuli (16).  
Intuitively, the foremost resource of pluripotent stem cells are the embryonic stem cells 
(ESCs). They are obtained from the inner cell mass of blastocysts and can generate all 
cell types in the body. Due to the tumorigenic potential of ESCs (17) as well as the 
legal and ethical considerations associated with their usage (18), the application of 
ESCs in tissue engineering at large remains rudimentary as of today.  
Recent establishment of induced pluripotent stem cells (iPSCs) generated directly from 
adult cells (e.g., epithelial cells) emphasizes their potential to derive patient-specific 
ESC equivalents. The technology of introducing four specific genes (Oct3/4, Sox2, c-
Myc, and Klf4), which encode transcription factors, could convert adult cells into 
iPSCs, as published by Shinya Yamanaka’s lab in 2006 (19). The iPSCs exhibit similar 
features to ESCs, including cell morphology, cell markers, growth properties, 
telomerase activity (20, 21) and giving rise to every other cell type in the body (19). 
These iPSCs seemingly present fewer ethical concerns than hESCs since they can be 
derived directly from adult tissues, thus bypassing the need for manipulating embryos. 
Moreover, each individual could have his/her own pluripotent stem cell line by a 
patient-matched manner. However, the major concern with the potential clinical 
application of iPSCs is their propensity to form tumors (22). Thus, more research is 
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still required to reveal the nature and the therapeutic usefulness of iPSCs to achieve the 
stage where therapeutic transplants can be deemed safe.  
Fortunately, these concerns are less pervasive in adult stem cells because of minimal 
tumorigenicity concerns (23). Moreover, adult stem cells are isolated from various 
tissues (including bone marrow, adipose tissue, umbilical cord and umbilical cord 
blood) and differentiate into cells of their own lineages or even atypical lineages in 
some cases (24). The main function of adult stem cells is to maintain and repair the 
tissue in which they are found. Some of the commonly applied adult stem cells in tissue 
engineering are mesenchymal stem cells (MSCs) (25), neuronal stem cells (NSCs) (26), 
hepatic stem cells (27) and hematopoietic stem cells (HSCs) (28) from both human or 
non-human sources. The most explored adult stem cells are human MSCs (hMSCs), 
owing to their wide range of sources and multiple differentiation abilities (Figure 1.1). 
They are attractive, being readily isolated from bone marrow (29), glomeruli (30), 
umbilical cords (31), umbilical cords blood (32), lacrimal glands (33) and other easily 
accessible sources such as adipose tissue (34) and peripheral blood (35). Under 
appropriate conditions, mainly via biochemical inducers, MSCs can differentiate into 
osteocytes, chondrocytes, adipocytes, myocytes and even trans-differentiate into 
hepatocytes, cardiomyocytes and neurons (23). Comparing to ESCs, adult stem cells 
have morelimited pluripotency and are often restricted to differentiate into lineages 
within germ layer. The ability of adult stem cells from one germ layer to differentiate 
into cell types from different germ layers is called trans-differentiation (36). By using 
the patients’ own hMSCs, it is possible for an autologous transplant and thus avoids 
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tissue rejection effects (37). 
 
Figure 1.1 hMSC sources and capability of differentiation and trans-differentiation. 
 
Different multipotent stem cells are also found in amniotic fluid and amniotic 
membrane (38-40). The amniotic fluid contains a heterogeneous mixture of multipotent 
cells, such as MSCs, embryonic-like stem cells and HSCs (41). Additionally, human 
amniotic epithelial cells (hAECs) can be isolated from the amniotic membrane and 
have shown multipotent potential, being able to differentiate into neural and glial cells 
(42), osteoblasts (43) and hepatocytes (44, 45). The amniotic fluid and amnion derived 
stem cells have non-tumor forming property, which is a similarity shared with adult 
stem cells. This property could be an advantage over hESCs and iPSCs when medical 
applications are considered (41). More importantly, ethical issues pertaining to the 





1.3  Nanomaterials in tissue engineering 
In most native tissues, cells are organized in a tissue-specific, three dimensional (3D) 
extracellular matrix (ECM), which comprises a complex network of nanoscale fibers 
forming highly structured local microenvironments (46). Cellular communication, 
transport of oxygen and nutrients, removal of wastes and cellular metabolites require 
such environment, where cellular orientation can be polarized and movement of 
contents can be directional. Hence, in tissue engineering, most of the engineered 
organs/tissues need support, named scaffold, for their formation from cells. These 
scaffolds usually serve the purposes of supporting cell proliferation and differentiation, 
enabling diffusion of vital cell nutrients and expressed products, and exerting certain 
mechanical and biological influences to the cells. It is generally hypothesized that a 
close imitation to the natural ECM could provide scaffolds with a more conducive 
environment to support the adhesion, migration, proliferation and differentiation of 
stem cells (47, 48). Many physicochemical properties of ECM can exert subtle effects 
on the surrounding cells’ biological cues. For one, we should notice the nanostructural 
features intrinsic to the natural ECM: (1) many tissues’ basement membranes exhibit 
enormous nanotopographies, which affect cellular behaviors including adhesion, 
proliferation, migration and differentiation (49); (2) ECM molecules, such as collagen 
and hydroxyapatite crystals in bone, exhibit several nanostructures which are 
hypothesized to contribute to cell matrix signaling (50). In order to better mimic the 
nanostructures in natural ECM, engineered nanomaterials, which are defined by the 
size of materials with at least one dimension less than 100 nm (51), have recently 
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emerged as promising candidates in producing scaffolds that resemble the ECM and 
efficiently replace defective tissues. For manipulating stem cells’ commitment, 
scaffolds derived from nanomaterials have been investigated over the past decade.  
Nanofibers are one the suitable nanomaterials for stem cell engineering. They are 
ranging from synthetic biodegradable polymers [PLLA (52), poly-(D, L-lactic-co-
glycolic acid) (PLGA) (53), polyvinyl alcohol (PVA) (54) or polycaprolactone (PCL) 
(55)] to natural materials such as collagen (56), gelatin (57) and chitosan (58). Besides 
biocompatibility and biodegradability, nanofibrous scaffolds are amenable to various 
functional modifications and can be prepared with 3D scale and highly porous network 
towards enhancing stem cell survival and proliferation or directing specific stem cell 
fates. Their utilization for nerve (59), cardiac, bone (60), skin, vascular and cartilage 
tissue engineering are intensively discussed in publications (61, 62). However, the 
intrinsic properties of these polymers generally lack additional multifunctional 
attributes such as adequate mechanical support, ability to guide/induce specific cellular 
processes (e.g., stem cell differentiation) (63). 
More recently, a carbon-based material, carbon nanotubes (CNTs), has been at the 
forefront of nanotechnology due to their unique properties, such as high conductivity, 
large surface-to-volume ratio, outstanding mechanical properties as well as 
nanotopographic features (64). Thus, their multifunctional characteristics have been 
exploited for the development of novel scaffolds to modulate stem cell differentiation 
for a range of applications in the field of tissue engineering. For example, CNTs are 
suitable materials for bone scaffolds due to their low density, high thermal conductivity 
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and elastic modulus (stiffness), and remarkable flexibility (65, 66). For the first time, a 
former study from A/P Giorgia Pastorin’s lab found that the thin films of polyethylene 
glycol (PEG) linked multi-walled CNTs (PEG-CNTs) were not cytotoxic and 
accelerated the osteogenic differentiation of hMSCs, to a similar extent as compared to 
hMSCs cultured with a commonly used growth factor, the bone morphogenetic protein-
2 (BMP-2) (67). This was demonstrated by quantitative real-time polymerase chain 
reaction (RT-PCR) analysis, immunostaining and alizarin red quantification (calcium 
mineralization). It was hypothesized that these regular nanoscale undulations on PEG-
CNT film surface, which resembled the nanoarchitecture of the natural ECM, favored 
an efficient growth of hMSCs and eventually stimulated their further differentiation 
into bone cells. In neural engineering, CNTs are attractive materials because of their 
excellent electrical conductivity. Laminin/CNT thin films were developed and found to 
support human NSC (hNSC) growth and to be conducive to hNSC differentiation and 
successful excitation, from the observation of (1) extensive formation of functional 
neural network as indicated by the presence of synaptic connections; (2) generation of 
action potentials upon applying a lateral current through the CNT substrate by calcium 
imaging (68). The combination of CNT-based scaffolds and stem cells were also 
employed in cardiac muscle engineering for adjustment of the conductivity and 
mechanical strength of scaffolds to influence cardiomyocyte development. The 
research by Crowder SW et al. is a relevant example (69): as compared to the tissue 
culture polystyrene and PCL scaffolds, the electrospun PCL/CNT scaffolds enhanced 
the cardiomyogenic differentiation of hMSCs in the presence of 5-azacytidine (69). 
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More examples about the combination of CNT-based scaffolds and stem cells for tissue 
engineering are summarized in Table 1.1. 
 
Table 1.1 Application of CNT-based scaffolds and stem cells in tissue engineering 
Scaffold Stem cells Application areas References 
Oxidized CNTs 
(single-walled) 




Rat MSCs Bone engineering (71). 
CNT (multi-walled) 
array 
hMSCs Bone engineering (72) 
CNTs (multi-walled) 
Human adipose-
derived stem cells 
Bone engineering (73) 
PCL/CNTs (multi- 
walled) composite 
hMSCs Bone engineering (74) 
Aligned CNTs (single-
walled) 
hMSCs Bone engineering (75) 
PLLA/CNT (single-
walled) nanocomposite 
hMSCs Bone engineering (76) 
PEG-CNT (multi-
walled) films 





















































Table 1.1 Application of CNT-based scaffolds and stem cells in tissue engineering 
(continued) 






Human decidua parietalis 










































CNTs can be seen as cylindrical tubes of rolled graphene sheets (Figure 1.2). Based on 
the composition of a single tube or concentric cylinders, CNTs are divided into single-
walled CNTs or multi-walled CNTs, both of which have similar properties in general. 
During chemical modification, the outer walls of multi-walled CNTs can protect the 
inner CNTs from surface modification, thus preserving the intrinsic properties. 
However, the electrical and mechanical properties of single-walled CNTs can change 
upon functionalization, due to the structural defects of C=C bond breakages through 
chemical process (89). Other advantages of multi-walled CNTs over single-walled 
CNTs include higher tensile strength (90, 91), ease of mass production and low product 
cost. Therefore, multi-walled CNTs are more frequently used than single-walled CNTs 





Figure 1.2 Schematic illustration of (A) single-walled and (B) multi-walled CNTs. 
 
In the past several years, CNT toxicity to cells and tissues has received a great deal of 
attention (92, 93). CNTs were shown to inhibit proliferation of HEK293 cells and to 
decrease cell adhesion in a dose- and time-dependent manner (94). In another study, 
the potential pulmonary toxicity of CNTs in mice was investigated and it was 
considered that chronic inhalation and/or exposure to CNTs could be a serious 
occupational health hazard (95). However, controversy exists with some studies 
reporting that CNTs are non-cytotoxic and excellent substrates for cellular growth. 
Mooney et al. reported that CNT suspension displayed good biocompatibility with 
hMSCs, and supported proliferation as well as differentiation of hMSCs in the presence 
of an induction medium (96). In addition, exposure of adipose-derived stem cell 
(ADSCs) to a wide range of dispersed CNTs (0.1, 1, 10, 20, 50, 100 μg/ml) for 3 and 7 
days revealed that low-dose CNTs (0.1 and 1μg/ml) increased viability and 
proliferation in mild ranges, but a high dose of CNTs inhibited proliferation and 
reduced the viability of ADSCs (97). Nowadays, there have been extensive efforts, 
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through synthesis, purification and functionalization, toward mitigating nanotube 
cytotoxicity and improving their biocompatibility (98-100). For example, a non-
covalent functionalization scheme was exploited to allow carboxylic acid moieties to 
be attached to the CNT surface, thereby creating stable aqueous dispersions and 
limiting cytotoxicity (101). Additionally, Allen et al. demonstrated biodegradation of 
CNTs through natural enzymatic catalysis using horseradish peroxidase (102). 
Furthermore, Dumortier et al. demonstrated that CNTs functionalized with PEG chains 
did not show toxic effects when tested in a wide variety of immune cell types (103). 
Therefore, few clear conclusions have emerged from this body of work to date, due in 
part to the large degree of inherent variability between the fabrication methods, purity 
and functionalization of CNTs, as well as differences concerning the dose, mode of 
administration and type of exposure to cells and tissues (104). 
Graphene is another carbon-based nanomaterial with a one-atom-thick sheet of carbon 
atoms arranged in a 2D honeycomb structure. It has received increasing attention for 
biomedical applications because of the remarkable properties like high surface area, 
high mechanical strength, and ease of functionalization (105). More importantly, 
graphene can be synthesized in a relatively pure form, making cell testing to be less 
affected by impurities (106). Although studies on graphene materials are still at a 
nascent stage, graphene has been widely used to help the development of stem cell 
engineering research. For example, a graphene substrate was observed to work as a 
promoter for human NSCs differentiation into neurons (107); Graphene (108) and 3D 
graphene foams (109) had the ability to facilitate the osteogenic differentiation of 
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hMSCs; Lee et al. reported that graphene enhanced the cardiomyogenic differentiation 
of human ESCs (110). 
 
1.4  Differentiation induction factors for stem cell differentiation  
To induce different lineage commitment, stem cells may require the appropriate 
extracellular signals to trigger or to promote this process. Differentiation induction 
factors from protein and chemical origins can constitute an important class of such 
stimuli. From protein sources, biological growth factors have been widely 
demonstrated to induce the differentiation of stem cells. For example, bone 
morphogenetic proteins (BMPs), such as BMP-2 and BMP-7, are known as the most 
potent growth factors for directing the osteogenesis of stem cells like MSCs and 
enhancing bone formation (111); transforming growth factors 1 and 3 (TGF-1 and 
TGF-3) can be utilized to enhance the differentiation of MSCs into chondrocytes 
(112); brain-derived neurotrophic factor (BDGF), platelet-derived growth factor 
(PDGF), glial cell line-derived neurotrophic factor (GDNF) (113) and basic fibroblast 
growth factor (bFGF) (114) are used to induce neural differentiation of NSCs, while 
epidermal growth factor (EGF) and bFGF can be utilized to promote neural trans-
differentiation of MSCs (115); hepatocyte growth factor (HGF), EGF, TGF and 
insulin-like growth factor are employed to help MSCs to trans-differentiate into 
hepatocytes (116-118). Additionally, many non-proteinaceous chemicals are 
frequently used in the specific differentiation of stem cells in vitro. For instance, 
dexamethasone (DXM), ascorbic acid and β-glycerophosphate are typical osteogenic 
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inducers for MSCs (119); retinoic acid (RA) is used for neural differentiation of ESCs 
(120) and β-mercaptoethanol (BME) is utilized for neural trans-differentiation of 
MSCs (115); DXM, RA, sodium butyrate and nicotinamide (NTA) act as inducers for 
hepatic trans-differentiation of MSCs (116-118). 
The devoted growth factors are either locally or systemically produced in vivo, and 
circulated to ECM to exert a paracrine or autocrine effect at injured sites for tissue 
formation or maturation. In contrast, some of the chemical differentiation induction 
factors such as DXM and BME cannot be generated in vivo and are mainly used in vitro 
stem cell culture. To support tissue regeneration in an in vitro setting, these biochemical 
agents can be loaded into scaffolds to promote or to induce differentiation of stem cells. 
However, the employment of differentiation inducers is dispensable under specific 
circumstances where only stem cells and scaffolds remain successful in tissue 
engineering. For example, oxidized CNTs were demonstrated to induce and to maintain 
neural differentiation of hMSCs without any exogenous differentiating factors, as 
evidenced by the protein expression (85). This outcome represents a development that 
accentuates the role of the scaffold in substituting some functions of differentiation 
factors besides just serving as structural support. 
Beside differentiation inducer factors, physical cues from the immediate environment, 
such as stiffness or the surface roughness of the surrounding structure, can alter or 
enhance the fate and differentiation of the stem cells (121). Related knowledge will be 




Overall, CNT-based scaffolds have been demonstrated to support or to enhance the 
attachment, growth and differentiation of various stem cells in vitro (Figure 1.3). The 
combination of CNT-based scaffolds and stem cells is a versatile strategy and can cover 
a broad range of applications (i.e., bone, nerve, and cardiac muscle, Table 1.1), with or 
without the differentiation induction factors (Figure 1.3). The permutation of this 
combination is not exhaustive. For this reason, more explorations in other tissue types, 
such as skeletal muscle and liver can be done and this needs further investigation. It is 
expected that the combination of stem cells and CNT-based scaffolds will develop into 
a powerful tool in tissue engineering for the innovative treatment of many diseases. 
This thesis will focus on a couple of these possibilities. 
 
 
Figure 1.3 CNT-based scaffolds supported or enhanced the attachment, growth and 





CHAPTER 2.  Hypotheses and objectives 
2.1  Thesis rationale and hypotheses 
As we discussed in Chapter 1, carbon nanotube (CNT)-based scaffolds supported cell 
growth and enhanced differentiation of stem cells into diverse lineages. Despite these 
potential biomedical applications, one challenge in using pristine CNTs is that they are 
extremely hydrophobic and rapidly precipitate in aqueous solutions, thus mitigating 
their beneficial characteristics. To improve the property of CNTs, polyethylene glycol 
(PEG) can be used to modify CNTs’ surfaces and increase their hydrophilicity to 
facilitate scaffold preparation, cell adherence and growth (67, 122). Moreover, PEG 
linked multi-walled carbon nanotube (PEG-CNT) films were demonstrated to 
accelerate the osteogenic differentiation of human mesenchymal stem cells (hMSCs) 
by A/P Giorgia Pastorin’s group (67). Therefore, it was hypothesized that PEG-CNTs 
may be a versatile coating material which provides nanoscale surface roughness and 
thus enhances the course of various stem cell differentiation towards dedicated lineages 
under suitable conditions. However, many of these possibilities have not been tested. 
(1) CNTs have been used as an auxiliary material to modulate the conductivity or 
mechanical strength of scaffolds towards myotube formation from skeletal muscle 
progenitor cells in skeletal muscle engineering (123, 124). However, whether or not the 
intrinsic properties of CNTs themselves can influence the myogenesis of stem cells has 
not been fully investigated. Therefore, it is a novel and bold idea to determine the 
influence of PEG-CNTs to the skeletal myogenesis of hMSCs which have multi-lineage 
differentiation ability. The result would subsequently guide us towards successful 
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design of CNT-based scaffolds for engineering specific skeletal muscle tissues. 
(2) Besides the surface features, the stiffness of scaffolds plays a critical role in the 
process of stem cell differentiation. Given the fact the PEG-CNT films were much 
stiffer than human muscle, we hypothesized the development of PEG-CNTs coated 
poly-acrylamide hydrogel (PA) with stiffness mimicking muscle (CNT-PA-M) would 
improve the myogenesis of hMSCs for skeletal muscle engineering. 
(3) With the aim to further challenge the capability of PEG-CNT coating in directing 
stem cells’ lineages and on the basis of importance of scaffold’s stiffness, it was 
deduced that the PEG-CNTs coated PA with customized stiffness (CNT-PA-L) would 
be able to recreate the environmental profile of a healthy liver and could enhance the 
hepatic differentiation of a different stem cell source, the human amniotic epithelial 
cells (hAECs).  
 
2.2  Objectives 
Based on the rationale and hypotheses, the overall aim of this thesis is to explore the 
versatility of PEG-CNTs as a coating material in enhancing the differentiation of stem 
cells into dedicated lineages under proper conditions. Therefore, we propose the 
following specific objectives:  
(1) Preparation and characterization of PEG-CNT films, and investigation of the 
influence of PEG-CNT films in modulating skeletal myogenic differentiation of 
hMSCs;  
(2) Development and characterization of CNT-PA-M, as well as examination of the 
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effect of CNT-PA-M towards myogenic differentiation of hMSCs; 
(3) Fabrication and characterization of CNT-PA-L, followed by determination of 
whether CNT-PA-L can enhance the hepatic differentiation of hAECs.  
 
2.3  Experimental design 
To achieve these objectives, three studies were designed and summarized in Figure 2.1.  
In Chapter 3, we will describe how we improve the PEG-CNT film preparation method 
and comprehensively characterize the films’ surface roughness, hydrophilicity and 
stiffness. After culturing hMSCs on PEG-CNT films, cell viability will be tested to 
ensure the safety of application of PEG-CNT films in tissue engineering. The myogenic 
differentiation of hMSCs (with/without myogenic induction medium) on PEG-CNT 
films will be investigated through comparison with controls (cover slips) by 
quantitative real-time polymerase chain reaction (RT-PCR) and western blot assays. 
The osteogenesis, chondrogenesis and adipogenesis of hMSCs on PEG-CNT films will 
be determined to address if the myogenesis is lineage specific. 
In Chapter 4, we will fabricate a novel scaffold of CNT-PA-M which has PEG-CNTs 
as the coating and muscle stiffness mimicked PA as the basement membrane. Since 
collagen is often used as a default ECM protein for surface coating in facilitating cell 
attachment, growth, differentiation, migration, and tissue morphogenesis, collagen-I 
(Col-I, the most abundant type of collagen in the body) coated PA with skeletal muscle 
mimicked stiffness (Col-PA-M) will be prepared as a control (125). To ensure 
successful development of scaffolds, characterization such as surface morphology and 
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stiffness will be performed. Finally, the myogenic differentiation of hMSCs 
(with/without myogenic induction medium) on CNT-PA-M, Col-PA-M and cover slips 
will be examined by cell viability and immunostaining studies.  
In Chapter 5, PA with liver stiffness will be used as the basement support to be coated 
with PEG-CNTs (CNT-PA-L) and Col-I (Col-PA-L). After characterization of these 
scaffolds in terms of surface morphology and stiffness, hAECs will be seeded on CNT-
PA-L, Col-PA-L and cover slips, and cultured in hepatic induction medium. The 
hepatic differentiation of hAECs on different substrates will be compared with cell 
viability, RT-PCR, immunostaining and hepatic function assays.  
We will finally sum up the overall findings and future perspectives in Chapter 6. 
 
 
Figure 2.1 Thesis experimental design outline.  
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CHAPTER 3.  Spontaneous and specific myogenic 
differentiation of human mesenchymal stem cells on 
polyethylene glycol-linked multi-walled carbon nanotube films 
for skeletal muscle engineering 
3.1  Introduction 
3.1.1  Skeletal muscle injury and therapy 
Skeletal muscles, which are approximately 40% of all muscles and located throughout 
the human body, are responsible for the control of voluntary movement as well as the 
maintenance of structural contours and postures of the body (126). Skeletal muscle 
abnormalities can arise from a multitude of conditions including developmental 
anomalies, trauma, rhabdomyolysis of skeletal muscle, muscular dystrophy, diabetic 
tissue damage, irradiative injuries and physical injuries (127-129). As skeletal muscle 
tissues show limited regeneration capacity, these conditions, coupled with substantive 
surgical ablations, often result in permanent damage and loss of physical mobility (130). 
The current remedy for replacing skeletal muscle tissues involves autografts (implants 
from patient to himself/herself), allografts (implants from a donor) or artificial grafts. 
Considering the severe limitations of these therapies, such as limited supply 
(autografts), potential immune rejection and viral infections (allografts), adverse 
inflammatory and immune rejections or even direct toxicity (artificial grafts) (detailed 





3.1.2  Cells in skeletal muscle engineering 
Skeletal muscle cells (SKMCs) are produced when multiple myoblasts, muscle 
progenitor cells, differentiated and fuse together to form a fiber, within which each 
myoblast contributes one nucleus (131). The myoblasts that do not form SKMCs 
usually spontaneously dedifferentiate back into satellite cells. The satellite cells are 
specialized myoblast sub-population located between the sarcolemma and the basal 
lamina of the muscle fibers and are considered the muscle-specific stem cells (132). 
They are capable of intrinsic repair of the mature skeletal muscle and are involved in 
scar tissue formation which leads to a loss of functionality in the injured areas (133, 
134). Satellite cells represent the natural first choice in cellular therapeutics for skeletal 
muscle due to their intrinsic myogenic commitment, and thus they are frequently used 
in skeletal muscle engineering (135, 136). However, the application of satellite cells is 
problematic because of invasive harvesting method, difficult purification, low 
expansion capability with low yield (13) and limited source due to low incidence of 
satellite cells in skeletal muscle (i.e., 1%–5%) (137, 138). 
In this light, human mesenchymal stem cells (hMSCs) have attracted much attention 
due to their wide range of sources and capabilities of self-renewal in an undifferentiated 
state for prolonged time and multi-lineage differentiation, which has been discussed in 
details before (Chapter 1, section 1.2, page 5). The hMSCs were frequently investigated 
for skeletal muscle engineering because they have minimal tumorigenicity or ethic 
concerns, and can be coaxed to differentiate into myocytes upon proper stimuli (23). 
A simple way to induce skeletal myogenesis of hMSCs is to culture hMSCs in 
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myogenic medium supplemented with chemical inducers such as dexamethasone 
(DXM), hydrocortisone (127, 139) and 5-azacytidine (15, 140). However, most 
chemical differentiation inducers including those mentioned above are controversial 
exogenous agents with potential to cause unexpected effects to the differentiation of 
hMSCs. In one study, Merrison et al. reported that collagen substrates and medium 
supplemented with multiple growth factors increased the expression of skeletal muscle 
markers in hMSCs as demonstrated by quantitative real-time polymerase chain reaction 
(RT-PCR) (141). Unfortunately, immunostaining revealed no change in expression of 
muscle-related proteins including desmin, myoblast differentiation protein (MyoD), 
myogenic factor-5 (Myf5) in hMSCs, indicating that these conditions only partially 
stimulated myogenic differentiation pathways. Alternatively, the use of conditioned 
media prepared from primary muscle precursor cell culturing media has been shown to 
improve the efficiency of skeletal myogenic differentiation of MSCs from human and 
mouse (15, 142). However, such method requires invasive harvesting of primary 
SKMCs, which is hard to implement in clinical settings. Therefore, the potential use of 
hMSCs for skeletal muscle engineering awaits an efficient and minimally-invasive 
protocol that guides hMSCs towards prescribed skeletal myogenic differentiation in a 
controlled and reproducible manner.  
 
3.1.3 Carbon nanotubes (CNTs) as scaffolds in skeletal muscle engineering 
Because of the unique mechanical and electrical properties, CNTs have been used in 
skeletal muscle engineering as an auxiliary material to modulate the conductivity or the 
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mechanical strength of scaffolds towards the myotube formation from fusion of 
myoblasts (123, 124, 143, 144). For instance, electrospun polyurethane/CNTs (multi-
walled and single-walled) scaffold was used to modulate skeletal myotube formation 
from murine SKMCs (143); polycaprolactone (PCL)/oxidized CNT (multi-walled) 
hydrogel was demonstrated to support the proliferation of rat SKMCs and displayed 
more myotube cells comparing to the CNT free hydrogel (123); a recent study found 
that murine SKMCs grown on vertically aligned CNTs (multi-walled) within 
methacrylated gelatin hydrogels yielded a higher number of myotubes than cells 
cultured on hydrogels with randomly or horizontally aligned CNTs, respectively (124). 
However, the cells employed in these studies were skeletal muscle progenitor cells, 
which are harvested from skeletal muscle and have an inherent predisposition towards 
myotube formation (134). Additionally, there is no research investigating the sole 
influence of CNTs in skeletal muscle engineering. Therefore, we envisage to determine 
the influence of CNTs to the skeletal myogenesis of hMSCs which have multi-lineage 
differentiation ability. The result would subsequently guide us towards successful 
design of CNT scaffolds for engineering specific skeletal muscle tissues.  
As we discussed in Chapter 2 (Section 2.1, page 15), pristine CNTs are extremely 
hydrophobic and thus the more hydrophilic polyethylene glycol-linked multi-walled 
carbon nanotubes (PEG-CNTs) were used in this study. We aimed to prepare and 
comprehensively characterize PEG-CNT films, and to investigate the role of the 




3.2  Materials and methods 
3.2.1  Synthesis and characterization of PEG-CNTs  
Multi-walled CNTs (courtesy of Professor S. Ramaprabhu, Indian Institute of 
Technology Madras, Indian) were prepared by chemical vapor deposition method as 
previously reported (145). The outer diameter of CNTs was 30-40 nm with an average 
internal diameter of about 10 nm, and the CNT length ranged from a few hundred nm 
to 1 μm. Pristine CNTs were functionalized to synthesize PEG-CNTs according to the 
procedure reported by Zhao et al. (146) and illustrated in Figure 3.1. Briefly, 100 mg 
of pristine CNTs were oxidized by sonicating (Sono Swiss, Switzerland) in the mixture 
of 5 ml of concentrated nitric acid (Fluka Analytical, USA) and 15 ml of sulfuric acid 
(Merck Chemicals, Germany) for 6 hours. The obtained oxidized CNTs were 
thoroughly washed with distilled water until the pH value was around 6. The product 
was then filtered through 0.2μm pore size polytetrafluoroethylene (PTFE) membrane 
(Millipore, Germany) and re-suspended in a small amount of distilled water. The 
oxidized CNTs were finally lyophilized to get dry powder.   
The oxidized CNT powder (100 mg) was added to anhydrous dimethylformamide 
(DMF, Sigma Aldrich, USA) and sonicated for 30 minutes to give a homogenous 
suspension. Oxalyl chloride (4 ml, Sigma Aldrich, USA) was then added drop wise into 
the oxidized CNT suspension at 0 °C. The mixture was stirred at 0 °C for 2 hours and 
then at room temperature for another 2 hours. Finally, the temperature was increased to 
85 °C, and the mixture was stirred for overnight to remove excess oxalyl chloride. PEG 
(1 g, Sigma Aldrich, USA, MW=600) was added to the suspension and stirred at 100°C 
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for 5 days. When cooled to room temperature, the mixture was filtered through 0.2μm 
pore size PTFE membrane and thoroughly washed with distilled water. The black PEG-
CNTs were collected in a small amount of distilled water and lyophilized. 
Thermogravimetric analysis (TGA, TA instrument 2960 SDT V3.0F, USA) was 
employed to determine if the successful conjugation of PEG to CNTs was achieved. 
Samples were heated to 1000 °C, ramping at 5 °C/min at atmosphere pressure in air.  
 
 
Figure 3.1 Schematic representation of the synthesis of PEG-CNTs. (a) HNO3/H2SO4 
(v/v, 1:3), sonication for 6 hours; (b) (COCl)2 (2 hours at 0 °C, 2 hours at room 
temperature, overnight at 85 °C); (c) PEG (100 °C, 5 days). 
  
3.2.2  Preparation and characterization of PEG-CNT films 
The PEG-CNT films were prepared by a drop-drying method. Briefly, PEG-CNTs were 
sonicated in DMF to obtain 2 mg/ml suspensions. The suspensions were subsequently 
dropped onto pre-heated round cover slips maintained at 160 °C. After the evaporation 
of DMF, PEG-CNT films were formed and the films were kept at 160 °C for another 5 
minutes to remove residual DMF. The deposited PEG-CNT amount on cover slips was 




around 2.8 μg/mm2.  
The PEG-CNT film surfaces were imaged by helium ion microscope (HIM, Carl Zeiss, 
Germany) and then measured under atomic force microscope (AFM, Dimension 
FastScan, Bruker, Germany) for surface roughness characterization with bare cover 
slips as a control. The static contact angle measurements of PEG-CNT films and cover 
slips were conducted by applying a 1 μl drop of deionized water to the surface and 
capturing an image parallel to the image plane at high magnification (WV-CP300 
Day/Night Fixed Indoor Camera, Panasonic, Japan). Analysis was carried out with 
ImageJ software (National Institutes of Health, USA) by fitting an ellipsis to the water 
droplet and measuring the angle to the substrate surface baseline. The PEG-CNT film 
thickness was detected by scanning electron microscope (SEM, JSM-6701F, JEOL, 
Japan) at the cross-section of the films. Mechanical strength of PEG-CNT films and 
cover slips was determined by MTS Nanoindenter XP (Agilent, USA). Loading rate 
was fixed at constant strain rate at 0.05 s-1 and the holding time at maximum load was 
10 s. The unloading rate was the maximum loading rate incurred during loading. 
Continuous stiffness measurement (CSM) method was used to measure the Young’s 
modulus and hardness. The reported values were averaged in depth range of 400-500 
nm.  
 
3.2.3  Cells and culture condition 
Human MSCs (hMSCs, Lonza, Switzerland) were expanded at 5000 cells/cm2 in 
growth medium consisting of high glucose-Dulbecco’s Modified Eagles Medium 
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(DMEM, Sigma Aldrich, USA), 10% fetal bovine serum (FBS, PAA Technologies, 
Austria), 1% penicillin/streptomycin (Pan Biotech, Germany), 1 mM sodium pyruvate 
(Gibco, USA) and 1 mM non-essential amino acid (Sigma Aldrich, USA). For all 
experiments, hMSCs at passage 5 were used. Human SKMCs (Lonza, Switzerland) 
were seeded at 3500 cells/cm2 in SKGM Bullet Kit (Lonza, Switzerland). All cells were 
maintained at 37°C, 5% CO2 air atmosphere and medium was replaced twice per week. 
Sub-culturing was conducted when cells reached 80-90% confluence with 0.25% 
trypsin–EDTA (Invitrogen, USA).  
For myogenic induction, hMSCs were cultured up to 21 days. The hMSCs at 3000 
cells/cm2 were seeded on various substrates and maintained in growth medium for 7 
days. Myogenesis was then induced by changing growth medium with myogenic 
medium for another 14 days. The myogenic medium consisted of growth medium 
supplemented with 100 nM DXM (Sigma Aldrich, USA) and 50 μM hydrocortisone 
(Sigma Aldrich, USA) (147). For the non-induced hMSCs, growth medium was used 
throughout the study. We included 4 experimental groups: (1) non-induced hMSCs 
plated on cover slips as a negative control; (2) myogenically-induced hMSCs plated on 
cover slips; (3) non-induced hMSCs plated on PEG-CNT films; (4) myogenically-
induced hMSCs plated on PEG-CNT films.  
 
3.2.4  Cell viability of non-induced and myogenically-induced hMSCs 
The cell viability was determined on day 1, 7, 14 and 21 by staining the cells with 
fluorescent live/dead viability/cytotoxicity kit (Invitrogen, USA) according to the 
29 
 
manufacturer’s instruction. Briefly, a mixture of 2 μM calcein-AM and 4 μM EthD-1 
was added to the hMSC samples after washing with PBS at each time point. The 
samples were incubated in dark at 37 °C for 45 minutes and then examined by a 
confocal microscope (Olympus, Japan). 
This fluorescent live/dead viability/cytotoxicity kit was also used for a quantitative test 
of cell viability. For this study, hMSCs were seeded on a 96-black-walled, clear bottom 
plate. On the day of experiment (day 1, 7, 14 and 21), cells were gently washed with 
PBS three times and 100 μl PBS was left after the last wash. The reagent containing 2 
μM calcein-AM and 4 μM EthD-1 (100 μl) was added into the wells. The samples were 
incubated in the dark at room temperature for 45 minutes and the fluorescence was 
measured by a plate reader (EnSpire Multimode Plate Reader, Perkin Elmer, USA). 
The calcein-AM was read at an excitation wavelength of 485 nm and emission 
wavelength of 530 nm while the EthD-1 was read at an excitation wavelength of 530 
nm and emission wavelength of 645 nm. The fluorescence intensity of non-induced 
hMSCs plated on cover slips and PEG-CNT films at day 1 were used as control for 
cover slip and PEG-CNT film samples respectively. Values of cell viability were 
expressed as a fold change of that from the control. Results represented 5 independent 
biological replicates. 
 
3.2.5 Quantitative RT-PCR 
At the end of 21 days of incubation, hMSCs were processed for the isolation of total 
RNA using RNeasy Mini Kit (Qiagen, Netherlands) according to the protocol given by 
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the manufacturer. Total RNA concentration and purity were determined (OD 260/280 
within 1.9-2.1) using Nanodrop (NanoDrop-ND1000, USA). cDNAs of respective 
samples were synthesized from RNA using SuperScript III first-strand synthesis system 
(Invitrogen, USA).  
Quantitative RT-PCR was performed with Fast SYBR Green mater mix (Qiagen, 
Netherlands) and primers using iCycler iQ Real Time PCR Detection System (Bio-Rad 
Laboratories, USA). The primers for myogenic and osteogenic markers as well as 
hMSC-feature genes were designed by web-based Primer 3 software 
(http://frodo.wi.mit.edu/) and the sequences were listed in Table 3.1. The cycle thermal 
profile comprised an enzyme activation at 50 °C for 2 minutes, followed by an initial 
denaturation at 95 °C for 10 minutes, 40 cycles of 95 °C for 15 s and 60 °C for 1 minute. 
The primer and cycle thermal profile for adipogenic and chondrogenic markers were 
cited from references and the primer sequences were shown in Table 3.2. Expression 
changes of various genes were analyzed using Livak (2-ΔΔCT) method to normalize gene 
expression to the reference gene GAPDH and expressed as fold change as compared to 















Table 3.1 Sequences of primers used in RT–PCR analysis of hMSC-feature genes, 









size (bp)  
CD73  NM_001204813.1 
GCC GCT TTA 
GAG AAT GCA 
AC 
CTC GAC ACT TGG 
TGC AAA GA 
234 
CD90  NM_006288.3  
CCC AGT GAA 
GAT GCA GGT TT  
CAG CCT GAG 
AGG GTC TTG TC  
183  
CD105  NM_001114753.1  
CAC TAG CCA 
GGT CTC GAA 
GG  
CTG AGG ACC 
AGA AGC ACC TC  
165  
MyoD NM_002478.4  
CCG CTT TCC 
TTA ACC ACA 
AAT  
CGG CTG TAG ATA 
GCA AAG TGC  
98  
Desmin  NM_001927.3 
TCG GCT CTA 
AGG GCT CCT C 
CGT GGT CAG 
AAA CTC CTG GTT 
194 
MHC NM_001100112.1 
GAT GGC ACA 
GAA GTT GCT 
GA 
CTT CTC GTA GAC 
GGC TTT GG 
177 
TnC  NM_003279 
TGG GGA CAT 
CAG CGT CAA G 
CCA AGA ACT 




TGG CTC ACC 
TAT GCT GCT C 
GAC AGT GCG 
TCG TCC ATG T 
101 
Col-I NM_000089.3  
TCC AAA GGA 
GAG AGC GGT 
AA  
CAG ATC CAG CTT 
CCC CAT TA  
112  
OCN NM_199173.4  
GAC TGT GAC 
GAG TTG GCT 
GA  
CTG GAG AGG 
AGC AGA ACT GG  
119  
OPN NM_000582.2  
CAT CAC CTG 
TGC CAT ACC 
AG  
GCC ACA GCA TCT 
GGG TAT TT  
87  
ALP NM_001127501.2  
CCT CCT CGG 
AAG ACA CTC 
TG  
CCA CCA AAT GTG 
AAG ACG TG  
64 
GAPDH NM_002046.4 
ATG TTC GTC 
ATG GGT GTG 
AA 
TGT GGT CAT 
GAG TCC TTC CA 
144 
CD73=cluster of differentiation 73, CD90=cluster of differentiation 90, CD105=cluster 
of differentiation 105/endoglin, MHC=myosin heavy chain 2, TnC=fast skeletal 
troponin C, Ryr=ryanodine receptor 1, Col-I=collagen type I, OCN=osteocalcin, 







Table 3.2 Sequences of primers used in RT–PCR analysis of adipogenic and 
chondrognenic markers 
Gene 
Forward primer sequence 
(5’->3’) 




GCC TTT TTG TCC ATC 
CCT TTT TTC 
CTC CAG GTA GCC TCC 
CTC ACT CC 
(149) 
Aggrecan 
CAC GGC TTC TGG 
AGA CAG GAC TG 
TGT TGG GGA GGT GGC 
TGT TTC G 
(149) 
Col-II 
ACC TCA CGC CTC 
CCC ATC ATT G 
ACA TCA GGT CAG GTC 
AGC CAT TCA G 
(149) 
AP2 
CCA GGG ACT TTG 
GGT ACG TG 
GGT TGA GAA ATT CAG 
CTA CTG CT 
(150) 
Adiponectin 
TCC TGC CAG TAA 
CAG GGA AG 




TCA TTC CCG GAG 
TAG CAG AGT 
GGC CAC AAG TTT TGG 
CAC C 
(150) 
Col-II=collagen type II, AP2=adipocyte protein 2, LPL=lipoprotein lipase, Sox9= SRY 
(sex determining region Y)-box 9 
 
3.2.6 Western blot 
After 21 days of incubation, cells on the substrates were lysed with cell lysis buffer (50 
mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 10% Glycerol, 10% Triton X-100, 
10 mM sodium pyrophosphate, 100 mM sodium fluoride, 2 mM sodium orthovanadate, 
2 mM PMSF, 0.1 μg/ml aprotinin). The BCA protein assay (Thermo Scientific Pierce, 
USA) was performed to determine protein concentration. Equal protein lysates (~20 
μg) were resolved by SDS-poly-acrylamide gel and transferred to polyvinylidene 
difluoride (PVDF) membranes (Bio-Rad, USA) for western blot. Primary antibodies 
were anti-MyoD (1:1000, mouse monoclonal, Abcam, UK), anti-desmin (1:500, rabbit 
monoclonal, Abcam, UK), anti-myosin heavy chain (MHC, 1:200, mouse monoclonal, 
Santa Cruz, USA) and anti-β-actin (1:10000, Abcam, UK). Secondary antibodies were 
anti-mouse and anti-rabbit horseradish peroxidase conjugated secondary antibodies 
(Thermo Scientific Pierce, USA) at 1:10000 dilution. Each membrane was exposed to 
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SuperSignal West Femto chemiluminescent substrate (Thermo Scientific Pierce, USA). 
Protein bands were then detected with enhanced chemiluminescence by feature-SRX-
101A (Konica Minolta, USA). 
 
3.2.7  Myogenic differentiation of hMSCs on graphene sheets 
The graphene coated cover slips were provided by Barbaros Ozyilmaz’s lab, Graphene 
Research Center, National University of Singapore. Graphene grown by chemical 
vapor deposition (CVD) on Cu-foil was transferred to cover slips by poly-(methyl 
methacrylate) (PMMA) mediated wet transfer and using ammonium persulfate to etch 
the Cu-foil, as described elsewhere (152). Both of non-induced hMSCs and 
myogenically-induced hMSCs were cultured on cover slips and graphene sheets. At the 
end of 21 days incubation, cells were processed to mRNA isolation, cDNA synthesis 
and RT-PCR analysis of myogenic markers. Results represented 3 independent 
biological replicates. 
 
3.2.8  Statistical analysis 
For each experiment, replicates were averaged and presented as mean ± standard 
deviation (SD). Statistical significance was determined with SPSS. Cell viability and 
the fold changes of each gene in RT-PCR study were analyzed using a two-way 
ANOVA with substrate and induction as independent variables. The P-values less than 




3.3  Results 
3.3.1  Synthesis and characterization of PEG-CNTs  
Figure 3.2 showed the TGA graphs and the derivative curves of pristine CNTs, oxidized 
CNTs and PEG-CNTs. Compared with pristine CNTs and oxidized CNTs, an additional 
peak was observed from 400 °C to 450 °C in the derivative curve of PEG-CNTs, as 
shown by the arrow. It was postulated that this peak was due to the decomposition of 
PEG from PEG-CNTs, which was in agreement with the results obtained previously in 
A/P Giorgia Pastorin’s lab (67). 
 
3.3.2 Characterization of PEG-CNT films 
The typical HIM top-view image showed that PEG-CNT films prepared using a drop-
drying method displayed a homogenous and smooth surface with nanorange 
undulations (Figure 3.3A). Moreover, the film surfaces exhibited an orderly fashion of 
PEG-CNTs. The AFM scan of 1 μm2 of surface topology substantiated the HIM results 
as the representative PEG-CNT film showed a small nanoscale Root Mean Square 
(RMS)-roughness of 75±9 nm with the waviness of PEG-CNT bundles. Comparing to 
this, the plain cover slip was extremely smooth and displayed surface roughness within 
2 nm (Figure 3.3B). The hydrophilicity of each substrate was evaluated by water 
contact angle as presented in Figure 3.3C. The contact angle was found to be 17.0±3.1° 
for PEG-CNT films whereas 63.1±5.6° for cover slips, indicating that PEG-CNT films 





Figure 3.2 TGA graphs and derivative curves of pristine CNTs, oxidized CNTs and 
PEG-CNTs. 




Figure 3.3 (A) HIM image of the surface topography of PEG-CNT films; (B) AFM 
image of PEG-CNT film and cover slip surface at 1 μm2; (C) representative contact 
angles of water on a PEG-CNT film and a cover slip. 
 
Figure 3.4A showed SEM images at the cross section of PEG-CNT films, which did 
not possess stratified layers but rather formed blended and porous films. The estimated 
thickness of PEG-CNT film was around 5 μm. The typical load–depth curves for PEG-
CNT films and cover slips obtained from nanoindentation tests were illustrated in 
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Figure 3.4B and C. It revealed the average Young’s modulus and hardness of PEG-
CNT films to be 557.3±70.0 MPa and 26.3±3.0 MPa, respectively, indicative of high 
mechanical strength. Cover slips alone exhibited much higher stiffness than PEG-CNT 
films, with Young’s modulus of 71.1±1.2 GPa and hardness of 6.8±0.1 MPa. 
 
 
Figure 3.4 (A) SEM image at the cross section of PEG-CNT films, left: 2000× 
magnification; right: zoom in view at 10000× magnification; representative load-depth 
curves of (B) PEG-CNT films and (C) cover slips by nanoindentation tests. 
 
3.3.3  Viability of non-induced and myogenically-induced hMSCs 
The fluorescent live/dead staining (Figure 3.5A) indicated that both cover slips and 
PEG-CNT films well supported hMSC attachment and maintained the cell viability 
without any dead cell staining. Congruent with this result, the EthD-1 reading for dead 
cells was minimal in every sample for the quantification. Therefore, only the reading 
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of calcein-AM, which symbolizes viable cells, was taken in account for the calculation 
of cell viability.  
Figure 3.5B showed that the cell number of non-induced hMSCs on cover slips 
increased rapidly after 7 days to an increase of 2.24 ± 0.08 folds as compared to day 1. 
The cell number reached a plateau of 2.49 ± 0.24 folds at day 14 and decreased 
marginally to 2.07 ± 0.08 folds at day 21. The myogenic induction decreased hMSC 
number to 2.22 ± 0.17 folds at day 14 and 1.63 ± 0.06 folds at day 21. Likewise, PEG-
CNT films adequately supported hMSC attachment and growth over 21 days of 
incubation (Figure 3.5B). The cell number on PEG-CNT films gradually increased to 
1.17 ± 0.06 folds at day 7, 1.32 ± 0.09 folds at day 14 and 1.29 ± 0.05 folds at day 21 
for non-induced hMSCs. With myogenic induction, the fold change of cell number 
were 1.12 ± 0.10 at day 14 and 1.21 ± 0.07 at day 21. Two-way ANOVA was used to 
investigate the influence of substrate and induction to the cell viability of hMSCs. Both 
PEG-CNT films and myogenic induction exerted significant effects to the reduced cell 





Figure 3.5 (A) Live and dead staining; (B) quantitative viability of hMSCs (induced to 
myogenic differentiation or not, n=5) on cover slips and PEG-CNT films during 21 
days incubation. For quantitative analysis, two-way ANOVA showed substrate term 
P<0.001 for day 14 and day 21, induction term P<0.01 for day 14 and day 21, two-way 
interaction term P>0.05 for day 14 and P<0.001 for day 21. The P-values less than 0.05 
denotes statistical significance. 
 
3.3.4  Gene expression analysis by RT-PCR 
To determine if the treated hMSCs repressed the hMSC features and acquired 
myogenic gene markers distinctive in myogenesis, RT-PCR analysis was performed 
after 21 days of incubation. For the investigation of hMSC features (Figure 3.6), 
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myogenic induction significantly depressed the expression of cluster of differentiation 
73 (CD73), cluster of differentiation 90 (CD90) and cluster of differentiation 
105/endoglin (CD105). On the other hand, PEG-CNT films alone exerted significant 
effect to the reduction of CD90, but not to CD73 and CD105 (Figure 3.6). Therefore, 
myogenic induction was necessary for the repression of hMSC-feature markers. The 
P-value from two-way ANOVA for two variables of substrate and induction was 
illustrated in Table 3.3.  
 
 
Figure 3.6 Depressed hMSC-feature genes, n=5. Two-way ANOVA showed substrate 
term P<0.05 for CD90 while P>0.05 for CD73 and CD105, induction term P<0.001 
for CD73, CD90 and CD105, two-way interaction term P<0.01 for CD73 while P>0.05 
for CD90 and CD105. The P-values less than 0.05 denotes statistical significance. 
 
Looking at the acquisition of myogenic phenotype, the expression of early myogenic 
markers of MyoD and desmin as well as the late phase gene of MHC was significantly 
up-regulated by about 2-fold in hMSCs plated on PEG-CNT films as compared to the 
negative control (Figure 3.7A). However, the myogenic differentiation of hMSCs was 
not influenced by myogenic induction as there was no significant difference in 
myogenic marker expression between non-induced and myogenically-induced groups. 
Additionally, between the two variables, only PEG-CNT film was responsible for the 
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significant up-regulation of fast skeletal troponin C (TnC) and ryanodine receptor 1 
(Ryr) (Figure 3.7B). 
Overall, there was no myogenic differentiation of hMSCs on cover slips and the 
myogenic induction could not improve the myogenesis of hMSCs on PEG-CNT films. 
These results indicated PEG-CNT films played a vital role in skeletal myogenic 
differentiation of hMSCs and a spontaneous skeletal myogenic differentiation of non-
induced hMSCs on PEG-CNT films was observed. 
 
 
Figure 3.7 (A) Up-regulation of myogenic genes in non-induced hMSCs on PEG-CNT 
films, n=5. Two-way ANOVA showed substrate term P<0.001 for MyoD, desmin and 
MHC, induction term P>0.05 for MyoD, desmin and MHC, two-way interaction term 
P<0.001 for MyoD while P>0.05 for desmin and MHC; (B) up-regulation of SKMC-
specific genes in non-induced hMSCs on PEG-CNT films, n=5. Two-way ANOVA 
showed substrate term P<0.001 for TnC and Ryr, induction term P>0.05 for TnC and 
Ryr, two-way interaction term P<0.05 for TnC and P>0.05 for Ryr. The P-values less 




Since the hMSCs can differentiate into various lineages beyond myocytes, markers for 
adipogenic, chondrogenic and osteogenic lineages were also investigated to assess 
whether this preferential myogenic differentiation of hMSCs was specific. In terms of 
osteogenesis (Figure 3.8A), comparing to the negative control, significant decrease of 
collagen type I (Col-I) expression was observed in PEG-CNT film groups, whereas 
myogenic induction did not change this expression. For osteocalcin (OCN) expression, 
there was no significant impact exerted by either substrate or induction. In addition, 
PEG-CNT films significantly up-regulated osteopontin (OPN) levels in hMSCs while 
myogenic induction significantly suppressed OPN expression. On the contrary, a 
significant suppression of alkaline phosphatase (ALP) was observed in PEG-CNT film 
groups, whereas a significant up-regulation of ALP was seen with myogenic induction. 
In terms of chondrogenesis (Figure 3.8B), results from a two-way ANOVA showed that 
PEG-CNT film, myogenic induction and their interaction played roles in the significant 
down-regulation of SRY (sex determining region Y)-box 9 (Sox9) compared to the 
negative control. PEG-CNT films also exerted significant influence on the depressed 
aggrecan expression, whereas no significant difference was found between non-
induced and myogenically-induced hMSCs. Within all treated groups, the hMSCs 
expressed similar levels of collagen type II (Col-II) to the negative control group 
without any statistically significant difference. Finally for adipogenesis (Figure 3.8C), 
both PEG-CNT film and myogenic induction had significant influence to the decreased 
adipocyte protein 2 (AP2) expression in treated hMSCs compared to the negative 
control group. Furthermore, there was no significant difference between any two 
43 
 
groups in adiponectin expression. Moreover, two-way ANOVA proved significant 
effects of PEG-CNT film, myogenic induction and interaction between the two 
variables to the expression of lipoprotein lipase (LPL). Notably, myogenically-induced 
hMSCs significantly increased LPL levels to more than 200-fold and 40-fold on cover 
slips and PEG-CNT films, respectively, whereas non-induced hMSCs on PEG-CNT 











Figure 3.8 (A) Osteogenic gene expression, n=5. The two-way ANOVA showed 
substrate term P<0.01, induction term P>0.05, two-way interaction term P>0.05 for 
Col-I; substrate term P>0.05, induction term P>0.05, two-way interaction term P<0.01 
for OCN; substrate term P<0.001, induction term P<0.05, two-way interaction term 
P>0.05 for OPN; substrate term P<0.01, induction term P<0.001, two-way interaction 
term P>0.05 for ALP; (B) chondrogenic gene expression, n=5. The two-way ANOVA 
showed substrate term P<0.001, induction term P<0.001, two-way interaction term 
P<0.001 for Sox 9; substrate term P<0.01, induction term P>0.05, two-way interaction 
term P<0.01 for aggrecan; substrate term P>0.05, induction term P>0.05, two-way 
interaction term P>0.05 for Col-II; (C) adipogenic gene expression, n=5. The two-way 
ANOVA showed substrate term P<0.01, induction term P<0.001, two-way interaction 
term P>0.05 for AP2; substrate term P>0.05, induction term P>0.05, two-way 
interaction term P>0.05 for adiponectin; substrate term P<0.001, induction term 
P<0.001, two-way interaction term P<0.001 for LPL. The P-values less than 0.05 
denotes statistical significance. 
 
To summarize, PEG-CNT films contributed to the significant up-regulation of 
myogenic markers of MyoD, desmin, MHC, TnC, Ryr and osteogenic marker of OPN, 
as well as significant down-regulation of hMSC-feature marker of CD90, osteogenic 
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markers of Col-I and ALP, chondrogenic markers of Sox9 and aggrecan, and 
adipogenic markers of AP2 and LPL. Overall, PEG-CNT films coaxed hMSCs-towards 
the phenotype of SKMCs (Figure 3.9 and Table 3.3). However, myogenic induction on 
the other hand led to significant increase of osteogenic marker of ALP and adipogenic 
marker of LPL, and significant suppression of hMSC-feature marker of CD73, CD90, 
CD105, osteogenic marker of OPN, chondrogenic marker of Sox9 and adipogenic 
marker of AP2.  
 
 
Figure 3.9 Fold change of hMSC-feature, myogenic, SKMC-specific, osteogenic, 







Table 3.3 P-value from two-way ANOVA of fold change for two variables of substrate 
and induction on cover slips and PEG-CNT films 
 variables 
Genes Substrate Induction Substrate*Induction 
CD73 0.312 2.308×10-8* 0.002* 
CD90 0.043* 2.120×10-4* 0.937 
CD105 0.314 1.233×10-6* 0.373 
 
MyoD 2.980×10-8* 0.167 4.530×10-4* 
Desmin 3.615×10-6* 0.503 0.949 
MHC 9.919×10-7* 0.502 0.994 
TnC 3.279×10-8* 0.259 0.024* 
Ryr 9.118×10-5* 0.092 0.413 
 
Col-I 0.006* 0.096 0.609 
OCN 0.807 0.088 0.001* 
OPN 5.995×10-8* 0.023* 0.276 
ALP 0.004* 2.069×10-5* 0.056 
 
Sox9 1.086×10-9* 1.595×10-14* 1.086×10-9* 
Aggrecan 0.005* 0.113 0.002* 
Col-II 0.302 0.911 0.361 
 
AP2 0.002* 5.549×10-7* 0.734 
Adiponectin 0.090 0.495 0.225 
LPL 4.712×10-10* 1.387×10-12 * 5.022×10-10* 
*indicated significant difference if P<0.05 
 
To decipher the mechanism underlying the improved myogenic differentiation of 
hMSCs on PEG-CNT films, the influence of graphene sheets (coated on cover slips) to 
skeletal myogenic differentiation of hMSCs was examined. When the hMSCs were 
grown on graphene sheets and induced to myogenic differentiation, the graphene sheets 
alone failed to elevate any myogenic marker, while myogenic induction only up-





Figure 3.10 Fold change of myogenic genes on cover slips and graphene sheets with 2- 
∆∆CT, n=3. Two-way ANOVA analysis showed substrate term P>0.05 for MyoD, desmin 
and MHC, induction term P<0.05 for MyoD and P>0.05 for desmin and MHC, two-
way interaction term P>0.05 for MyoD, desmin and MHC. The P-values less than 0.05 
denotes statistical significance. 
 
3.3.5  Protein expression analysis by western blot 
Lastly, we evaluated if the increase in myogenic mRNA transcript levels was 
significant enough to drive to specific myogenic lineage protein expression. Comparing 
to the negative control, the expression of MyoD and desmin was marginally higher in 
the myogenically-induced hMSCs cultured on cover slips (Figure 3.11). For MHC 
expression in hMSCs on cover slips, there was no difference between the non-induced 
and myogenically-induced hMSCs. However, MyoD, desmin and MHC were more 
strongly detected in the hMSCs cultured on PEG-CNT films with/without myogenic 
induction. In all, the western blot analysis (Figure 3.11) well confirmed the above RT-





Figure 3.11 Western blot of myogenic protein and actin expression in non-induced 
hMSCs on cover slips (lane 1), myogenically-induced hMSCs on cover slips (lane 2), 
non-induced hMSCs on PEG-CNT films (lane 3) and myogenically-induced hMSCs 
on PEG-CNT films (lane 4). Actin was used as a loading control. 
 
3.4  Discussion 
In this study, we prepared and characterized PEG-CNT films, and then explored the 
ability of PEG-CNT films to modulate skeletal myogenic differentiation of hMSCs. 
Central to our findings, the spontaneous skeletal myogenic differentiation of hMSCs 
plated on PEG-CNT films represents an unprecedented observation and opportunity to 
promote the regeneration of injured skeletal muscle.  
As a starting point for this study, advancement in film preparation was performed. In 
the former study by A/P Giorgia Pastorin’s lab, PEG-CNT films were prepared by 
spraying PEG-CNTs water suspension with an airbrush onto pre-heated cover slips (67). 
Comparing to this method, the newly developed drop-drying method is more attractive 
because it is simple, cost-effective and scalable. Furthermore, the drop-drying method 
allows the control of film thickness by PEG-CNT concentration and suspension volume, 
thus minimizing batch-to-batch variability.  
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It was postulated that nanoscale surface roughness, which resembled the 
nanoarchitecture of the natural ECM, increased the opportunity for protein adsorption 
on scaffolds, facilitating stem cell attachment and differentiation (53, 153). Figure 3.3 
A and B showed that PEG-CNT films displayed a homogeneous surface with nanoscale 
roughness and an orderly fashion of PEG-CNTs. This regularity may be facilitated by 
hydrophilic PEG, which is linked to CNTs and wraps around the CNTs, reducing 
aggregation and finally favoring the ordered arrangement of PEG-CNTs into films. 
Besides the regular arrangement, the hydrophilic PEG block may provide PEG-CNTs 
with improved hydrophilicity (Figure 3.3 C) which could greatly enhance favorable 
cellular response including adhesion and differentiation (154, 155).  
It is widely accepted that the indentation depth should not exceed 10% of the sample 
thickness in order to obtain a true load–depth response of the tested material when it is 
supported by a hard substrate (cover slips in this study) (156). It is desirable to choose 
a depth range around 10% of film thickness to acquire mechanical strength for thin 
films. Since the estimated thickness of PEG-CNT films was around 5 μm (Figure 3.4A), 
the average Young’s modulus and hardness of PEG-CNT films and cover slips were 
reported in a depth range of 400-500 nm (Figure 3.4 B and C). A commonly known 
value for the Young’s modulus of a single multi-walled CNT is 1 TPa (90, 157), with 
a large variation from 0.40 to 4.15 TPa as reported by Treacy et al. (158). However, 
this was reported for the measurement in an axial direction. The PEG-CNTs in film 
was observed in a radial direction in this study (Figure 3.3 A and B). Previous studies 
of Young’s modulus of single CNT in the radial direction showed much lower values, 
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between 0.3 to 4 GPa (159). In our case, the average Young’s modulus of PEG-CNT 
films was 557.3±70.0 MPa, which correlated with the Young’s modulus of single CNT 
in the radial direction and further indicated the horizontal alignment of PEG-CNTs. 
Furthermore, since the PEG-CNT films are composed of a network of PEG-CNTs, the 
mechanical strength of the film might have been influenced by the weak inter-tube 
contacts such as van der Waals and electrostatic interactions (160).  
For cell culture experiments, we examined the possibility of alternative controls such 
as PEG-only substrates and oxidized CNT films besides uncoated cover slips. However, 
PEG-only matrix was deemed unsuitable since (1) the amount of PEG complexed in 
PEG-CNTs was very low (0.8%, mol/mol, PEG/CNTs) and such a control would be 
vastly different from PEG-CNTs to accurately represent the PEG effect in PEG-CNTs 
(67); (2) PEG alone, being highly water soluble, would instantaneously dissolve in 
culture medium; (3) it was reported that PEG alone typically exhibit minimal or no 
intrinsic biological activity in tissue engineering, because of the lack of mechanical 
support and non-adhesive nature of PEG chains which cannot significantly absorb 
proteins or cells (67, 161, 162). On the other hand, oxidized CNT films have been 
excluded from cell culture due to their instability and rapid breaking during cell 
culturing, which is in accordance with the previous report from A/P Giorgia Pastorin’s 
group (67). In contrast, the PEG-CNT films can keep its integrity and remained intact 
on cover slips after 21days of incubation. For these reasons, a cover slip-only control 
is the next best control, without having to introduce any other extraneous factors that 
can confound such comparison. 
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Cell growth and differentiation are generally alternative processes that affect stem cell 
phenotype. As stem cells differentiate, their rate of growth usually decreases (163, 164). 
Hence, our observation of relatively lower cell number with myogenic induction and 
slow cell growth on PEG-CNT films (Figure 3.5 B) may be due to the myogenic 
differentiation of hMSCs and thus suppressed the growth of hMSCs. This was also 
confirmed by the lack of overt cell death based on fluorescent live/dead staining (Figure 
3.5A). 
A discriminating phenotype of hMSCs is the presence of CD73, CD90 and CD105 
surface molecules, as stated by the mesenchymal and tissue stem cell committee of the 
international society for cellular therapy (ISCT) (165, 166). As shown in Figure 3.6, 
myogenic induction significantly down-regulated these CD genes in hMSCs, as 
compared to negative control. The suppressed hMSC-feature gene expression indicated 
that the myogenically-induced hMSCs were prone to differentiate. In contrast, PEG-
CNT films alone only significantly decreased CD90 level in the non-induced hMSCs, 
in which there was spontaneous skeletal myogenesis. It is possible that the culturing 
time of 21 days is not long enough to detect significant changes on CD genes. It was 
found that CD markers (such as CD73) in human adipose-derived stem cells remained 
stable in long-term culture (until passage 20) with growth medium (167).  
Myogenic regulatory factors (MRFs) are the master regulators of skeletal myogenesis. 
As a member in MRFs, MyoD is required for the determination of skeletal myogenic 
lineages at the early stage (168, 169). Desmin, a muscle-specific intermediate filament 
protein, also represents one of the earliest myogenic markers (170, 171). Although it 
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presents early in the development of myocytes, it is only expressed at low levels, and 
increases as the cell nears terminal differentiation. Contrary to this, MHC is expressed 
in myogenic precursors undergoing terminal differentiation (139). Therefore, the 
unanimous increased expression of MyoD, desmin and MHC in differentiated hMSCs 
charted the progressive myogenic lineage development of hMSCs by both RT-PCR and 
western blot studies (Figure 3.7A and 3.11). Moreover, TnC expresses exclusively in 
skeletal muscle and Ryr is primarily expressed in skeletal muscle (172). Therefore, up-
regulated expression of TnC and Ryr in the differentiated hMSCs indicated that the 
hMSC-derived myoblasts may be committed towards SKMC development. The 
highlight of our experimental outcomes is the observation that the expression of 
myogenic and SKMC-specific markers significantly increased by the presence of PEG-
CNT films while myogenic induction alone failed to do so (Figure 3.7 and 3.11). This 
suggests that PEG-CNT films alone, without the presence of myogenic inducers like 
DXM and hydrocortisone, could trigger the myogenesis of hMSCs (at the transcript 
and protein expression levels). This is a great achievement because myogenesis was 
reportedly difficult to be induced in hMSCs (173). Additionally, there is no consensus 
achieved so far for the optimal skeletal myogenic medium of hMSCs (15). Therefore, 
DXM and hydrocortisone were chosen as myogenic inducers in this study because of 
the simplicity, cheap price and wide usage (127, 139). However, there is no well 
recognized way of controlling the optimal concentrations of these inducers for efficient 
differentiation with reduced or no side effects. Hence, a notable advantage of 
spontaneous myogenesis on PEG-CNT films is the removal of potentially noxious 
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DXM and hydrocortisone in the induction protocol.  
Besides, we considered the specificity of hMSC differentiation potential on PEG-CNT 
films. Osteogenic, chondrogenic and adipogenic marker investigation was therefore 
performed to rule out concurrent differentiation into different lineages. The justification 
of the selection of osteogenic, chondrogenic and adipogenic markers characterized in 
this study was shown in Table 3.4. Generally speaking, PEG-CNT films coaxed hMSC-
derived myoblasts similar to SKMCs in terms of non-enhancement or even a significant 
decrease of adipogenic, chondrogenic and osteogenic markers, as well as significant 
up-regulation of OPN (Figure 3.8 and 3.9). Myogenic induction also resulted in non-
enhancement or pronounced decrease of most adipogenic, chondrogenic and 
osteogenic markers. However, comparing to the negative control, there were 
statistically significantly increased levels of ALP and suprisingly high expression of 
LPL in the myogenically-induced hMSCs (Figure 3.8A and C). Hence, this study 
confirmed the possibility of removing myogenic inducers while still achieving the 
selectivity of skeletal myogenesis of hMSCs plated on PEG-CNT films alone. In short, 
the spontaneous myogenesis of hMSCs on PEG-CNT films may be a promising 









Table 3.4 Justification of the selection of osteogenic, chondrogenic and adipogenic 
markers characterized in this study 







Col-I The organic phase in bone is mainly composed of Col-I (174). 
OCN OCN is secreted solely by osteoblasts and implicated in bone 
mineralization and calcium ion homeostasis (175). It has been 
considered as a valid marker for fully-differentiated 
osteoblasts (176).  
OPN OPN is an extracellular structural protein and an organic 
component of bone. OPN expression in bone occurs by 
osteoblasts, osteocyctes (bone-forming cells) and osteoclasts 
(bone-resorbing cells) (177). 











Sox9 Sox9 is expressed in pre-cartilaginous condensing 
mesenchyme and maturing cartilage (179). Sox9 can bind 
directly to an enhancer in the Col-II gene and upregulate the 
Col-II expression (180). 
Aggrecan 
and Col-II 
Aggrecan and Col-II are integral part of the ECM in 









AP2 AP2 is a carrier protein for fatty acids that is primarily 
expressed in adipocytes and macrophages (182). 
Adiponectin Adiponectin is exclusively expressed in differentiated 
adipocytes and plays an important role in regulating energy 
metabolism mainly by increasing insulin sensitivity (183).  
LPL Synthesis of LPL is found to be dominant in adipose tissue. 
The LPL gene is transcriptionally activated at the early phase 
of adipocyte development (184). During adipocyte 
differentiation, there is a gradual increase of LPL mRNA that 
reaches a plateau level when the cell has matured into an 
adipocyte (185). 
 
In another study that we have performed as a comparator, graphene (a flat instead of 
cylindrical material with identical molecular construct with CNTs), when coated as a 
matrix, alone cannot trigger the myogenic differentiation of hMSCs (Figure 3.10). This 
result means that the building block that is common between graphene and PEG-CNTs 
is not the only determinant for the myogenesis of hMSCs. Instead, it was postulated 
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that the characteristics of PEG-CNT films, in terms of high hydrophilicity, the structure 
as nanotubes and orderly arrangement of PEG-CNTs, might facilitate the skeletal 
myogenesis of hMSCs without myogenic induction. A thorough study can be carried 
out in future to know the mechanism underlying the spontaneous myogenic 
differentiation of hMSCs on PEG-CNT films. 
It has been acknowledged that hMSCs have high sensitivity to the substrate “stiffness”, 
which directs the commitment towards different cell lineages (147). Softer matrices 
that mimic brain are neurogenic, stiffer matrices that mimic muscle are myogenic, and 
comparatively rigid matrices that mimic collagenous bone prove osteogenic. This may 
explain why hMSCs on the relatively softer PEG-CNT films (average Young’s 
modulus of 557.3±70.0 MPa) promoted skeletal myogenesis while the hMSCs the 
stiffer cover slips (average Young’s modulus of 71.1±1.2 GPa) failed to do so. It is 
worth mentioning that the highest up-regulation of myogenic markers in the hMSCs 
plated on PEG-CNT films did not exceed 4-fold, which is much lower than that in 
SKMCs (Figure 3.9). The weak myogenesis may be the result of different rigidity 
between PEG-CNT films and normal muscle (Young’s modulus of 12 KPa) (186). 
Hence, PEG-CNT scaffolds with skeletal muscle mimicked stiffness could be a future 











3.5  Chapter conclusion 
We report the fabrication and characterization of PEG-CNT films to support the growth 
and spontaneous skeletal myogenic differentiation of hMSCs. The PEG-CNT films, 
with high stiffness, presented nanoscale topography with orderly arrangement of PEG-
CNTs and superior hydrophilicity on the surface. It is interesting and groundbreaking 
to observe that the PEG-CNT films alone triggered skeletal myogenic differentiation 
of non-induced hMSCs, which was substantiated by cell viability, RT-PCR and western 
blot analyses (Figure 3.12). Furthermore, the absence of enhanced adipogenic, 
chondrogenic and osteogenic markers ruled out concurrent differentiation and 
indicated the PEG-CNT films helped hMSCs specifically differentiate into myoblasts. 
This is the first report to show that PEG-CNTs can be utilized to induce the skeletal 
myogenesis of hMSCs. Our findings in this study suggest that the combination of 
hMSCs as a cell source and PEG-CNTs as a scaffold material could represent a 
potential strategy for skeletal muscle engineering. 
 
 
Figure 3.12 A conclusion figure for Chapter 3: PEG-CNT films alone triggered skeletal 






CHAPTER 4.  Development and application of polyethylene 
glycol linked multi-walled carbon nanotubes coated hydrogels 
for myogenic differentiation of human mesenchymal stem cells 
4.1  Introduction 
The preceding Chapters alluded to the decisive role of the physical properties of 
scaffolds for subsequent growth, proliferation and differentiation of stem cells. In this 
Chapter, we will focus on the scaffold mechanical influence to the stem cells’ biological 
cues such as differentiation. For the combined application of nanomaterial scaffolds 
and stem cells in tissue engineering, it was demonstrated that the scaffold stiffness is a 
highly adjustable parameter that may control stem cell differentiation via regulation of 
distinct cytoskeletal organization and subsequent intracellular signaling events that 
transfer the substrate stiffness features to cell in order to modulate cell differentiation. 
In another words, stem cells have been found to “sense” small fluctuations in 
nanomatrix rigidity (187, 188). To investigate the influence of such interaction of stem 
cells and nanomaterials, mechanically distinct scaffolds with identical structure and 
surface chemistry were produced, i.e., the substrates’ surface characteristics were kept 
constant. The stiffer core-shell of poly-(ether sulfone)-polycaprolactone (PES-PCL) 
nanofibers with tensile strength of 30.6 MPa was compared against pure PCL 
nanofibers with tensile strength of 7.1 MPa. Differentiation results from murine 
embryonic mesenchymal progenitor cells on the matrixes indicated that the lower 
modulus PCL nanofibers facilitated chondrogenesis while the stiffer core-shell PES-
PCL nanofibers enhanced osteogenesis (188). In another work, three electrospun 
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nanofibrous silk protein mats with different stiffness of 4.8±0.4 GPa, 6.1±0.4 GPa and 
7.8±0.5 GPa were formed by varying the spinning distance. The impact of matrix 
rigidity features on chondrogenic differentiation of human mesenchymal stem cells 
(hMSCs) was clarified (187). After 4 weeks of culture, cells cultured on softer matrix 
(4.8±0.4 GPa) produced significantly more chondrogenesis regulating transcripts such 
as glycosaminoglycan, collagen type II (Col-II), SRY (sex determining region Y)-box 
9 (Sox9) and aggrecan. The authors postulated that on a relatively relaxed matrix 
(where nanofibers are loosely deposited), hMSCs could easily migrate and assume 
rounded and aggregated morphologies, enhancing chondrogenesis. Whereas, the stiffer 
matrices (6.1±0.4 GPa and 7.8±0.5 GPa) strongly upregulated RhoA expression and 
showed stress fibers. This might be explained in that the stiffer nanostructure mats 
generated mechanical stimulations to hMSCs and activated RhoA signaling that acts 
through RhoA/ROCK pathway, which might inhibit chondrogenesis (189). This study 
confirmed again that the softer underlying matrix is more favorable for chondrogenesis. 
Based on the discussed studies, suitable stiffness of scaffold could be manipulated to 
favor specific differentiation lineages, such as relatively stiffer for osteogenesis and 
less stiff for chondrogenesis. A recent study also applied stiffness controlled scaffolds 
for successful muscle engineering. In the study, a silk fibroin nanofiber scaffold (SS-
11.8) with compressive modulus of 16.7 KPa, similar to that of native muscle, initiated 
the myogenic differentiation of rat MSCs (190). After culturing on scaffolds in 
maintenance medium for 28 days, rat MSCs exhibited preferred myogenic 
differentiation on the SS-11.8 with significantly stronger expression of myoblast 
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differentiation protein-1 (MyoD) gene and protein in comparison to another silk fibroin 
nanofiber scaffold (SS-6.3, 6.2 KPa). 
Therefore, the current consensus is that the matrix stiffness should closely match that 
of the gross native tissue to elicit physiological cell responses. These known effects 
therefore compel us to examine stiffness as a mechanical influence for myogenic 
differentiation of hMSCs. Up till now, we know that polyethylene glycol linked multi-
walled carbon nanotube (PEG-CNT) films have enormously higher rigidity as 
compared to normal human muscle (Chapter 3, section 3.3, page 35), but not much has 
been done to modify this property. This gap creates an avenue for further exploration 
and optimization, and thus we consider poly-acrylamide hydrogel (PA) as a material 
with tunable stiffness to be used as a base to mimic the normal human muscle, whose 
stiffness (Young’s modulus) is around 12 KPa (186). PEG-CNTs can be subsequently 
coated on the muscle stiffness-mimicked PA to develop a novel scaffold, namely CNT-
PA-M. With this scaffold development and characterization, this study aimed to 
explore the influence of CNT-PA-M to modulate the myogenic differentiation of 
hMSCs, with an expectation of enhanced differentiation into myocytes in vitro.   
 
4.2  Material and methods 
4.2.1 Preparation of hydrogels 
A feasible approach to the preparation of PA from base solutions of 40% acrylamide 
(Bio-Rad, USA) and 2% bis-acrylamide (Bio-Rad, USA) has been published before 
(191). The final concentration of acrylamide and bis-acrylamide was 10% and 0.1%, 
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respectively to ensure the stiffness of PA close to 12 KPa (191). After mixing the 
solutions in water, hydrogels were fabricated by crosslinking with 
tetramethylethylenediamine (TEMED, 0.1%) and ammonia persulfate (APS, 1%) 
between two round cover slips. After gelation, the hydrogel surfaces were rinsed with 
water to remove any un-polymerized monomer.  
PEG-CNTs were synthesized following the procedure mentioned in Chapter 3 (section 
3.2.1, page 22). Random adsorption of PEG-CNTs on PA was achieved by immersing 
the hydrogels in 50 μg/ml PEG-CNT water suspension for 3 hours. The obtained CNT-
PA-M was rinsed with water and remained hydrated at 4 oC until use. 
As a control, collagen type I (Col-I) coated muscle stiffness mimicked PA (Col-PA-M) 
was prepared by covalently attaching Col-I molecules onto the PA surface (191, 192). 
According to the product instruction, a thin layer of 0.5 mg/ml sulfosuccinimidyl 6-
((4-azido-2-nitrophenyl) amino) hexanoate (sulfo-SANPAH, ProteoChem, USA) 
solution, which activated PA with an end of NHS ester that can react with Col-I, was 
placed on top of the hydrogels. Another PA without sulfo-SANPAH treatment was also 
used in the following steps as a comparison to ensure successful linkage of Col-I. The 
hydrogels were then exposed to ultraviolet light (OmniCure S2000, Excelitas 
Technologies, USA) for 10 minutes to crosslink the sulfo-SANPAH on hydrogel 
surfaces. The treated hydrogels were washed with 50 mM HEPES and soaked in a 
solution of 0.1 mg/ml Col-I derived from calf skin (EPC Elastin Products Company, 
USA) overnight at 4 oC. They were finally rinsed with water and kept in hydration at 4 
oC until use.   
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All the reagents used were sterile and the hydrogels were prepared in a biological safety 
cabinet to prevent contamination during cell culturing. Right before cell seeding, the 
hydrogels were placed in the biological safety cabinet under UV for sterilization. 
 
4.2.2 Characterization of hydrogels 
The presence of Col-I cross-linked on the Col-PA-M surfaces was verified by 
immunostaining with rabbit polyclonal Col-I antibody (1:500, Abcam, UK) in 2% 
bovine serum albumin (BSA) for 1 hour at room temperature. The hydrogel was then 
washed three times with PBS and incubated with goat anti-rabbit Alexa Fluor 488 
secondary antibody (1:500, Invitrogen, USA) for 1 hour at room temperature. After 
washing with PBS, the stained Col-PA-M was imaged using a confocal microscope 
(Fluoview, FV10i, Olympus, Japan). 
The surfaces of wet hydrogels with different coatings were observed with a phase 
contrast microscope (BX51, Olympus, Japan) and photos were taken by Olympus 
DP72 camera (Olympus, Japan). To view with higher magnification, the hydrogels 
were lyophilized, coated with gold and imaged with scanning electron microscope 
(SEM, JSM-6701F, JEOL, Japan). The stiffness of these hydrogels in wet state was 
quantified using an atomic force microscope (AFM, NanoWizard II, JPK instruments 
AG, Germany), which is a nanoindentation method of calculating elasticity. This 




4.2.3  hMSC culture condition 
The maintenance and myogenic differentiation of hMSCs were carried out with the 
same conditions as described in Chapter 3 (section 3.2.3, page 25). In this study, we 
included 6 experimental groups: (1) non-induced hMSCs plated on cover slips as a 
negative control; (2) myogenically-induced hMSCs plated on cover slips; (3) non-
induced hMSCs plated on Col-PA-M; (4) myogenically-induced hMSCs plated on Col-
PA-M; (5) non-induced hMSCs plated on CNT-PA-M; (6) myogenically-induced 
hMSCs plated on CNA-PA-M. 
 
4.2.4 Cell viability test 
An alamarBlue assay for cell viability was carried out at day 1, 7, 14, 21 to monitor the 
cell growth rate. Briefly, 10% alamarBlue (Invitrogen, USA) diluted in culture medium 
was added to cells and incubated for 1 hour at 37 oC. The medium was subsequently 
collected and the fluorescence was measured at an excitation wavelength of 565 nm 
and emission wavelength of 595 nm using a plate reader (EnSpire Multimode Plate 
Reader, Perkin Elmer, USA). Cells were washed three times with PBS and returned to 
fresh medium for further incubation. The fluorescent value of each sample at day 1 was 
defined as the control to normalize the respective sample data as fold change at other 
days. Results represented 3 independent biological replicates. Cell morphology at 
different time points was examined by a phase contrast microscope (CKX41, Olympus, 




4.2.5  Immunostaining 
At the end of 21 days differentiation protocol, cells were washed with PBS and fixed 
with 4% paraformaldehyde solution for 10 minutes at room temperature. Cell 
membranes were then permeabilized with 0.1% Triton X-100 for 10 minutes at room 
temperature. Non-specific sites of the samples were blocked using 2% BSA for 30 
minutes and cells were incubated overnight at 4 oC with one of the following primary 
antibodies in 2% BSA: anti-MyoD (1:200, mouse monoclonal, Abcam, UK), anti-
desmin (1:150, rabbit monoclonal, Abcam, UK) or anti-myosine heavy chain (MHC, 
1:500, mouse monoclonal, Santa Cruz, USA). The next day, the cells were washed three 
times with PBS and incubated with corresponding secondary antibody (anti-mouse 
IgG-FITC or anti-rabbit IgG-FITC, 1:500, Invitrogen, USA) for 1 hour at room 
temperature in the dark. After washing three times with PBS, the cells were incubated 
with 4, 6-diamidino-2-phenylindole (DAPI, 1:1000, Invitrogen, USA) to stain the 
nuclei. After washing five times with PBS, the stained cells were visualized and imaged 
using the confocal microscope. 
 
4.3 Results 
4.3.1 Characterization of hydrogels  
Shown from morphological characterization (Figure 4.1A), both of the stiffness-
customized hydrogels (i.e., Col-PA-M and CNT-PA-M) were transparent, thereby 
allowing cell and scaffold structure to be observed directly and clearly by optical 
microscope. In addition, optical microscope (Figure 4.1A) and SEM images (Figure 
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4.1B) indicated the precipitation of randomly agglomerated PEG-CNTs on the CNT-
PA-M surface. Comparing to the plain PA which had clear surface, red pigmentation 
on the surface of Col-PA-M was observed, suggesting the presence of sulfo-SANPAH 
linkage (Figure 4.1A). Immunostaining with Col-I verified the successful outcome of 
Col-I linkage on Col-PA-M with sulfo-SANPAH treatment (Figure 4.1C).  
In this study, the hydrogels were customized to mimic the stiffness of the normal human 
muscle for enhancing myogenic differentiation of hMSCs. Therefore, scaffold stiffness 
was tested by AFM nanoindentation and the results revealed that Col-PA-M and CNT-
PA-M had Young’s modulus of 8.72±0.49 KPa and 9.30±0.25 KPa, respectively 
(Figure 4.1D). Therefore, both hydrogels achieved desired stiffness which is close to 




Figure 4.1 Characterization of hydrogels. (A) Surface morphology of different 
hydrogels taken by microscope with bright field; (B) surface morphology of hydrogels 
observed by SEM; (C) fluorescent staining of Col-I on PA without (left)/with (right) 
the treatment of sulfo-SANPAH and subsequently incubated with Col-I to prepare Col-
PA-M; (D) stiffness (Young’s modulus) of hydrogels tested by AFM nanoindentation. 
The dotted horizontal line at Young’s modulus of 12 KPa is the stiffness of human 
muscle. 
 
4.3.2  Cell morphology and viability on hydrogel 
Figure 4.2 shows typical cell attachment and growth on cover slips, Col-PA-M and 
CNT-PA-M without/with myogenic induction. Elongated hMSCs were observed to be 
deposited on all scaffolds from day 1. The hMSCs on cover slips and Col-PA-M 
appeared more spread-out and flattened while cells on CNT-PA-M exhibited a more 
spindle-like shape. On cover slips and Col-PA-M, hMSCs (non-induced/induced) grow 
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significantly and formed a continuous monolayer on the scaffolds from day 7 onwards. 
In contrast, hMSCs on CNT-PA-M did not grow robustly, but their viability were well 
maintained. Over 21 days culturing, all hMSC groups grew as morphologically 
homogenous populations. The non-induced cells preserved the stretched morphology 
typical of hMSCs, whereas myogenic induction yielded polygonal shape for hMSCs, 





Figure 4.2 Cell morphology of hMSCs without/with myogenic induction on different 
substrates across 21 days. 
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Further quantifications of cell viability were performed on day 1, 7, 14 and 21 using an 
alamarBlue assay, which revealed that cell numbers on these scaffolds increased up to 
21 days with a plateau. As indicated in Figure 4.3, larger cell numbers were achieved 
on the controls of cover slips and Col-PA-M as compared to CNT-PA-M, consistent 
with earlier qualitative results (Figure 4.2). In other words, cover slips and Col-PA-M 
supported the growth of hMSCs while CNT-PA-M sustained the cell viability. With 
myogenic induction, the cell viability in all cases registered a decline, which can be 
easily observed on day 21.  
 
 
Figure 4.3 Viability of non-induced and myogenically-induced hMSCs on various 






In order to clarify the effects of CNT-PA-M on the differentiation of hMSCs, expression 
of MyoD, desmin and MHC proteins was studied at the end of 21 days incubation via 
immunofluorescence staining as a quick analytical method. Compared to cover slips, 
there was slightly higher fluorescence intensity of MyoD and MHC on hydrogels (Col-
PA-M and CNT-PA-M), regardless of the presence or absence of myogenic induction. 
(Figure 4.4A and C). Moreover, stronger expression of desmin appeared on hydrogels 
than on cover slips, without any clear difference between the myogenically-induced or 















Figure 4.4 Immunostaining of non-induced and myogenically-induced hMSCs on 
different scaffolds at day 21. The cells were stained for (A) MyoD (green), (B) 





The aim of this study was to investigate the influence of the improved CNT-PA-M to 
the myogenic differentiation of hMSCs. First of all, matrixes of CNT-PA-M and Col-
PA-M (as a control) were successfully prepared with a customized stiffness mimicking 
that of human muscle. Both of Col-PA-M and CNT-PA-M were transparent (Figure 
4.1A), thereby allowing cell and scaffold structure to be observed directly and clearly 
by optical microscope. This initial characteristic already spells an advantage of these 
hydrogels over PEG-CNT films which are opaque and can compromise cell and 
scaffold visualization. The sample optical microscope and SEM images of CNT-PA-M 
(Figure 4.1A and B) were taken after several washes post PEG-CNT incubation, thus 
the strong bonding of PEG-CNTs on PA surface would be a prerequisite for cell 
adhesion to support long-term cell culturing. This is proven by cell morphology study 
(Figure 4.2) that PEG-CNT coating on CNT-PA-M can still be seen after 21 days 
incubation. Moreover, the slightly higher stiffness of CNT-PA-M compared to Col-PA-
M (Figure 4.1D) could be attributed to the thin layer of PEG-CNTs attached on the 
hydrogel surface.  
The perturbation of cell morphology through changing surface mechanics can lead to 
tremendous biological implications. Several studies have noted that changes in cell 
shape regulated biological processes in cells, such as differentiation. For example, 
culturing in a chondrogenic differentiation medium with transforming growth factor β3 
(TGF β3) for 1 week, hMSCs spreading on large fibronectin islands (10,000 μm2) and 
un-patterned fibronectin-coated flat regions showed a greater expression level of 
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calponin (a smooth muscle cell marker), whereas hMSCs which were prevented from 
spreading when grown on small fibronectin islands (1024 μm2) showed an up-
regulation of Col-II, a chondrogenic marker (194). Changes in cell shape via 
rearrangements in the architecture and mechanics of the cytoskeleton, can 
mechanically induce focal adhesion, physically distort the nucleus, and even directly 
impact receptor-mediated signaling to alter cell differentiation (194, 195). Hence taking 
all these aspects together, multiple independent or inter-dependent mechanisms may 
transduce changes in cell shape to drive stem cell fate. As shown from Figure 4.2, 
myogenically-induced hMSCs adopted a new morphology with polygonal shape, yet 
maintaining cell viability. Therefore, the change in cell shape and cytoskeleton may 
correlate with the induction of hMSCs into muscle cells, which unfortunately was not 
observed in this study. However, it was also found that skeletal myogenic precursor 
cells extended into elongated spindles, similar to SKMCs, to execute their muscular 
functions (194). This finding may explain why non-induced hMSCs on Col-PA-M and 
CNT-PA-M, which retained the spindle-like shape, could also trigger the myogenesis 
of hMSCs (based on MyoD, desmin, MHC expression). More research is required to 
investigate how the change in cell shape influences the myogenesis of hMSCs. Since 
the shape of non-induced hMSCs is closer to SKMC shape compared to the 
myogenically-induced hMSCs, Col-PA-M and CNT-PA-M could represent easier and 
more controllable substrates to manipulate myogenesis of hMSCs. The decreased cell 
number of hMSCs on CNT-PA-M and myogenically-induced hMSCs may be a result 
of the transition from the growth phase to the differentiation phase, as we have 
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discussed in Chapter 3 (section 3.4, page 48). 
From the immunostaining (Figure 4.4), the stronger expression of myogenic proteins 
appeared on hydrogel scaffolds than on the negative control (non-induced hMSCs on 
cover slips), confirming the myogenic differentiation of hMSCs. No matter myogenic 
induction medium treated or not, hMSCs on hydrogel scaffolds obtained similar 
expression of MyoD, desmin and MHC. These results suggest the possibility of that 
tailoring matrix stiffness alone could intrinsically induce the differentiation of hMSCs 
to muscle cells. In future study, it would be a promising tool to fabricate PEG-CNTs or 
Col-I coated PA with controlled stiffness to match different tissues for diverse stem cell 
differentiation. 
In this study, myogenic induction medium failed to induce or enhance the myogenesis 
of hMSCs, which is a similar finding with that in Chapter 3. To improve myogenic 
differentiation of hMSCs, more robust myogenic induction medium (e.g., addition of 
SKMC specific growth factors) can be investigated in future. Furthermore, PEG-CNT 
coating had similar ability with Col-I coating in the spontaneous myogenesis of hMSC 
on hydrogels, indicating that PEG-CNTs worked as well as the widely used ECM 
protein, Col-I. 
On this note, the myogenic differentiation of hMSCs on PEG-CNT films was also 
studied with immunostaining in this research, but no result is displayed here due to a 
lack of signal for any myogenic protein. Moreover, the nuclei in hMSCs on PEG-CNT 
films stained with DAPI (fluorescence excitation/emission: 358/461 nm) cannot be 
detected, which may be due to the interference of PEG-CNTs. It has been reported that 
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CNTs exhibit strong optical absorption of wavelength below 380 nm due to its 
semiconducting excitonic energy levels (196). This overwhelming absorption under 
380 nm by CNT may suppress the fluorescence from DAPI at 358 nm excitation. Hence, 
YoYo-1 with fluorescence excitation/emission of 491/509 nm (Invitrogen, USA) was 
tested to locate the cell nuclei. Although the YoYo-1 staining can be observed in hMSCs 
grown on PEG-CNT films, it was not specific for nuclei and cell plasma was also 
stained. It was assumed that the PEG-CNTs had strong absorption of YoYo-1 dye and 
retained a large amount of the dye in the nanotubes, making it difficult to wash the dye 
out of the PEG-CNTs and leading to over-labeling of the cells. Hence, the images of 
hMSCs on PEG-CNT films were not shown. 
To further challenge the capability of PEG-CNT-based scaffolds in directing hMSCs’ 
lineages, trans-differentiation of hMSCs into hepatocytes, cardiomyocytes or neurons 
can be investigated on PEG-CNT-based scaffolds in future. 
 
4.5 Chapter conclusion  
In this study, muscle stiffness mimicked Col-PA-M and CNT-PA-M were prepared and 
evaluated with their biological effects on viability and myogenic differentiation of 
hMSCs. The hydrogels of Col-PA-M and CNT-PA-M well supported the growth of 
hMSCs and induced spontaneous myogenesis of hMSCs (Figure 4.5). This mechanical 
influence offers new opportunities to fine-tune existing scaffolds in support of different 
types of stem cell differentiation. In the following Chapter, we will exploit the 





Figure 4.5 A conclusion figure for Chapter 4: CNT-PA-M induced spontaneous 






CHAPTER 5.  Enhanced hepatic differentiation of human 
amniotic epithelial cells on polyethylene glycol linked multi-
walled carbon nanotubes coated hydrogels 
5.1 Introduction 
Liver performs a wide range of functions in metabolism and digestion, including 
detoxification, protein synthesis and bile production. As the main metabolic organ, the 
liver is exposed to large amounts of xenobiotics which makes liver very vulnerable 
(197). In addition, viral infections, genetic disorders or alcoholic injuries can cause 
liver failure, leading to acute or chronic liver diseases. Thus, human hepatocytes that 
are suitable for in vivo liver regeneration (the treatment of acute liver failures and end-
stage liver diseases), for construction of bio-artificial liver devices, or for in vitro 
testing of xenobiotics (e.g., drugs and pathogens) in the pharmaceutical industry, have 
been in great demand. However, such supplies are scarce due to the worldwide shortage 
of donor organs. Moreover, the application of fresh primary human hepatocytes as an 
attempt to enlarge this pool is severely limited by poor proliferation capacity and 
difficulty in maintaining metabolic functions when cultured in vitro (198). Therefore, 
it is both rational and necessary to develop a strategy that can circumvent donor liver 
scarcity for alternative cell sources, and yet be able to fully recapitulate hepatocyte 
phenotype and functions. In this respect, stem cell-derived hepatocytes believed to be 
a possible method that allows sustainable source of hepatocytes, have being pursued.  
Human amniotic epithelial cells (hAECs), with pluripotency and self-renewal 
capabilities, can be readily isolated from human amniotic membrane and maintained in 
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vitro (45, 199-202). Advantages of hAECs over other stem cell sources (e.g., human 
embryonic stem cells, hESCs and human mesenchymal stem cells, hMSCs) include 
abundant availability, non-invasive collection methods and ethically neutral since the 
placenta is usually discarded as bio-waste after parturition. More importantly, hAECs 
are not tumorigenic upon transplantation in comparison with hESCs (202) and are not 
known to induce immune reaction (203), thus allowing potential in vivo application. It 
has been reported that isolated hAECs resembled hepatic progenitor cell behaviors, 
such as albumin (ALB) secretion (204, 205) and expression of a subset of hepatocyte-
related markers including cytokeratin-18 (CK18), α-fetoprotein (AFP) and α1-anti-
trypsin (α1AT) (204, 206). All these properties make hAECs a promising cell source 
for liver engineering. Being fetal in origin, hAECs are highly plastic and have been 
differentiated into hepatocytes to different extents with a cocktail of growth factors, 
cytokines and hormones (44, 45, 207). When subjected to such differentiation medium, 
hAECs exhibited morphologic and phenotypic characteristics of hepatocytes, 
performed key hepatic functions in terms of ALB secretion, urea synthesis, 
indocyanine green (ICG) uptake and elimination, low-density lipoprotein uptake and 
inducible cytochrome P450 (CYP) activities. Yet, besides differentiation medium, 
culturing conditions could also be innovated to facilitate hepatic differentiation of 
hAECs. For example, co-culturing with mouse hepatocytes was shown to improve 
expression of hepatocytic markers (e.g., ALB and CYP) and metabolically active and 
inducible CYP3A enzyme functions in the hAEC-derived hepatocytes (207). 
Nonetheless, it is difficult and inconvenient to co-culture hAECs with mouse 
80 
 
hepatocytes for hepatic differentiation (207) and this combination also limits human 
implantation as a subsequent application. In another study, hAECs was encapsulated 
into barium alginate microspheres for hepatic differentiation along with enhanced 
hepatic functions in terms of urea output and CYP3A4 activity (44). While encouraging 
results were obtained, all of these studies shared a problem that the efficiency of hepatic 
differentiation remained low, and that the hepatically-differentiated hAECs were more 
fetal-like rather than mature adult hepatocytes. Consequently, a robust and efficient 
protocol for the differentiation of hAECs into functionally mature hepatocytes remains 
elusive. 
In addition to the use of hepatic differentiation medium, molecular scaffold for cell 
seeding is required for stem cell differentiation into hepatocytes ex vivo. As we 
discussed in Chapter 1, an ideal scaffold should mimic the structure and biological 
function of the in vivo liver microenvironment, the extracellular matrix (ECM). Carbon 
nanotubes (CNTs), with controlled nanoscale topography, may represent a promising 
material for the creation of liver ECM mimics (208). Compared to the cover slip control, 
aligned CNT (multi-walled) sheets and CNT yarns were proved to enhance liver-
specific functions of primary rat hepatocytes, including ALB production and CYP1A2 
induction (208). Albeit optimistic results were obtained, this study only investigated 
CNTs’ effects to maintain rat hepatocytes. So far, there was no research investigating 
the influence of CNTs on hepatic differentiation of stem cells, which is a more 
complicated process than just cell maintenance. Furthermore, pristine CNTs which are 
extremely hydrophobic with restricted application in tissue engineering was employed 
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in this earlier study (208). We therefore envisage that polyethylene glycol linked multi-
walled carbon nanotubes (PEG-CTNs) with increased hydrophilicity can be employed 
for the hepatic differentiation of hAECs (67, 122). This also represents the first attempt 
to exploit the versatility of CNTs in the differentiation of adult stem cells besides those 
of mesenchymal origin. 
Other than the compatibility of the nanoscale structure to support cell growth and 
differentiation, scaffold stiffness can exert significant influence in determining stem 
cell fate (147), which has been demonstrated in Chapter 4 (section 4.1, page 54). The 
current consensus is that the matrix stiffness should closely match that of the gross 
native tissue to elicit physiological cell responses. As a result, the employment of poly-
acrylamide hydrogel (PA) as a material with tunable stiffness was considered as a base 
to mimic the normal human liver, whose stiffness (Young’s modulus) is below 6 KPa 
(209, 210). PEG-CNTs were then coated on the liver stiffness-mimicked PA to develop 
PEG-CNTs coated PA (CNT-PA-L). With that, we positioned this study to explore 
the influence of CNT-PA-L to modulate the hepatic differentiation of hAECs, with 
the expectation of enhanced differentiation into functional hepatocyte-like cells 
(HLCs) in vitro.   
 
5.2  Materials and methods 
5.2.1 Preparation of hydrogels 
The PA was prepared with the method described in Chapter 4 (section 4.2.1, page 56). 
The final concentration of acrylamide and bis-acrylamide was 5% and 0.15%, 
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respectively to ensure the stiffness of PA lower than 6 KPa (191). The CNT-PA-L and 
collagen-I (Col-I) coated liver stiffness mimicked PA (Col-PA-L) were fabricated 
following the procedure mentioned in Chapter 4 (section 4.2.1, page 57).  
 
5.2.2 Characterization of hydrogels 
The surfaces and stiffness of hydrogels with different coatings were characterized as 
described in the previous chapter (Chapter 4, section 4.2.2, page 58). 
 
5.2.3 Cell culture  
hAECs were isolated from amniotic membrane as previously described (45, 199). They 
were maintained at 80,000 cells/cm2 in growth medium composed of high glucose-
Dulbecco’s Modified Eagles medium (Hyclone, USA), 20 ng/ml epidermal growth 
factor (BD Bioscience, USA), ITS premix (1:1000 dilution, BD Bioscience, USA), 10 
mM HEPES (Gibco, USA), 1 mM sodium pyruvate (Gibco, USA), Glutamax (1X, 
Gibco, USA) and 0.2 mM ascorbic acid (Sigma-Aldrich, USA). HepG2 cells (a 
hepatoblastoma cell line) were cultured in high glucose-Dulbecco’s Modified Eagles 
medium (Sigma-Aldrich, USA) with 10% fetal bovine serum (PAA Technologies, 
Austria). Sub-culturing was performed when hAECs and HepG2 cells reached 80-90% 
confluence with 0.25% trypsin–EDTA (Invitrogen, USA). Cryopreserved differentiated 
HepaRG cells (a human hepatic progenitor cell line, Life Technologies, USA) were 
thawed using HepaRG General Purpose medium and seeded into 96 well plates at a 
density of 100 000 cells/well. Medium was changed to HepaRG Tox media the next 
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day and refreshed every 3 days. Cells were ready for use after 7 days of maintenance. 
All cells were maintained at 37 °C, 5% CO2 air atmosphere. 
 
5.2.4  Hepatic differentiation of hAECs in vitro 
To induce hepatic differentiation of hAECs (80,000 cells/cm2), defined medium were 
used at different stages during 18 days incubation. The hepatic induction was 
performed with a 4-step protocol as described previously (45): (1) growth medium 
supplemented with B-27 (Biotool, USA) and 100 ng/ml Activin A (PeproTech, USA) 
from day 1 to day 5; (2) growth medium supplemented with B-27, 20 ng/ml bone 
morphogenetic protein-4 (BMP-4, Gibco, USA) and 10 ng/ml fibroblast growth factor-
2 (FGF-2, BD Bioscience, USA) from day 6 to day 10; (3) growth medium 
supplemented with B-27 and 20 ng/ml hepatocyte growth factor (HGF, PeproTech, 
USA) from day 11 to day 15; (4) Hepatocyte culture medium (HCM, Lonza, 
Switzerland) supplemented with 20 ng/ml Oncostatin M (R&D systems, USA) and 100 
μM Sodium taurocholate (Sigma-Aldrich, USA) from day 16 to day 18.  
The experimental samples were: (1) hAECs on collagen (Invitrogen, USA) coated 
cover slips in growth medium as a negative control, (2) HLCs (hAECs subjected to 
hepatic induction) on collagen coated cover slips, (3) HLCs on Col-PA-L, (4) HLCs on 





5.2.5  Cell viability test 
An alamarBlue assay for cell viability was carried out at the indicated time points (day 
3, 5, 8, 10, 13, 15, 18) to monitor the cell growth rate. The procedures of alamarBlue 
assay and cell morphology observation were shown in Chapter 4 (section 4.2.4, page 
59). The fluorescent value of each sample at day 3 was defined as control to normalize 
the respective sample data as fold change at other days. Results represented 3 
independent biological replicates. 
 
5.2.6 Real-time polymerase chain reaction (RT-PCR) 
After incubation for 18 days, hAECs and HLCs were processed for total RNA isolation, 
cDNA synthesis and quantitative RT-PCR study as mentioned in Chapter 3 (Section 
3.2.5, page 27). The primers were either designed using web-based Primer 3 software 
(http://frodo.wi.mit.edu/), cited from PrimerBank (http://pga.mgh.harvard.edu/primer 
bank/) or taken from other reported works. The primer information was listed in Table 
5.1. The cycle thermal profile comprised an enzyme activation at 50 °C for 2 minutes, 
followed by an initial denaturation at 95 °C for 10 minutes, 40 cycles of 95 °C for 15 s 
and 60 °C for 1 minute. Expression changes of various genes were analyzed using 
Livak (2-ΔΔCT) method (148). Each gene was first normalized to GAPDH to obtain CT 
and subsequently normalized to the negative control of non-induced hAECs on cover 





Table 5.1 Primer sequences of target and reference genes in RT-PCR analysis 
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5.2.7  Immunostaining 
At the end of the 18 days differentiation protocol, cells were processed for 
immunostaining with the methods described in Chapter 4 (section 4.2.5, page 59). The 
used primary antibodies are anti-human octamer-binding transcription factor 4 (OCT4, 
1:200, mouse monoclonal IgG, Santa Cruz, USA), anti-human AFP (1:200, goat 
polyclonal IgG, Santa Cruz, USA), anti-human ALB (1:200, goat polyclonal IgG, Santa 
Cruz, USA) or anti-human hepatocyte nuclear factor-4-alpha (HNF4α, 1:200, goat 
polyclonal IgG, Santa Cruz, USA). The secondary antibodies are donkey anti-goat IgG-
FITC (1:200, Santa Cruz, USA) or rabbit anti-mouse IgG3-FITC (1:200, Santa Cruz, 
USA). Pictures were taken and processed by ImageJ software (National Institutes of 
Health, USA) to quantify the average fluorescence intensity per area on OCT4, AFP, 
ALB and HNF4α stained images. Quantification was performed on at least 30 
randomly selected areas with cells.  
 
5.2.8 Hepatic function test 
5.2.8.1 Secretion of ALB 
Cell culture media were collected at every medium change (day 3, 5, 8, 10, 13, 15, 18), 
and spun at 10,000 rpm for 3 minutes to remove cell debris. Supernatants were stored 
at -20 oC until the day of assay. ALB production was assayed using a quantitative 
enzyme linked immunosorbent assay (ELISA) kit (Cygnus, USA) according to the 
manufacturer’s recommendations. The ALB concentration was normalized to cell 




5.2.8.2 Cellular uptake and clearance of ICG  
ICG (MP Biomedicals, France) was freshly dissolved in culture medium to 1 mg/ml 
and added to cells. After incubation for 1 hour at 37 oC in incubator, cells were rinsed 
three times with PBS and returned to fresh culture medium without ICG. The cellular 
uptake of ICG was immediately examined by a phase contrast microscope (CKX41, 
Olympus, Japan) and photos were taken by a DP26 camera (Olympus, Japan). At 6 
hours post incubation, a repeat imaging was performed to examine the clearance of 
ICG (212). 
5.2.8.3 Functional metabolism assay of CYP3A4 
Functional metabolism assay was carried out with a P450-Glo Luciferin-IPA kit 
(Promega, USA) according to manufacturer’s instructions. Cells were seeded on 96-
black-walled, clear bottom plates and processed for hepatic differentiation. After 18 
days incubation, previous culture medium was removed and replaced with 60 μl of 3 
μM Luciferin-IPA dissolved in culture medium. Control without cells was also 
performed for background luminescence correction. The plate was incubated for 1 hour. 
Thereafter, an aliquot of 50 μl medium was transferred to a white opaque polystyrene 
plate containing 50 μl of Luminescence Detection Reagent (LDR) in each well. The 
white plate was incubated for 20 minutes at room temperature and luminescence was 
read using a plate reader (Tecan, Switzerland). The cells were washed with PBS and 
alamarBlue assay was performed to test cell viability. The net luminescence signal due 
to CYP3A4 activity was calculated by subtracting the respective signal from control 
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wells without cells from the signal generated from wells with cells. The net 
luminescence signal was then normalized against the respective fluorescence signal 
from the alamarBlue assay. Results represented 3 independent biological replicates. 
5.2.8.4  Induction of CYP3A4 
Cells were seeded on 96-black-walled, clear bottom plates and processed for hepatic 
differentiation. At the end of 18 days incubation, the medium was changed to fresh 
culture medium containing 25 μM rifampicin in 0.1% DMSO or containing the vehicle 
of 0.1% DMSO (solvent control). The medium with rifampicin was refreshed every 24 
hours for 48 hours. Thereafter, rifampicin medium and solvent control medium were 
removed and cells were rinsed with PBS, followed by P450-Glo Luciferin-IPA and 
alamarBlue assays. The induction fold of CYP3A4 activity was determined by dividing 
normalized net luminescence of a treated group with that of the corresponding solvent 
control group. Results represented 3 independent biological replicates. 
 
5.2.9 Statistical analysis 
Quantitative data were represented as mean ± standard deviation (SD) with 3 
independent biological replicates. Statistical differences among various groups (n>2) 
were analyzed using SPSS with one-way ANOVA followed by Tukey post hoc test. 
Otherwise, a two-tailed unpaired student’s t test with SPSS was used. Significant 






This study explored the effects of CNT-PA-L on the hepatic differentiation of hAECs 
and we demonstrated that CNT-PA-L could enhance the differentiation of hAECs into 
functional HLCs. 
 
5.3.1 Characterization of hydrogels  
We set out to perform morphological characterization of the stiffness-customized 
hydrogels. Similar to the results in Chapter 4 (section 4.3.1, page 60), optical 
microscope (Figure 5.1A) and SEM images (Figure 5.1B) showed the precipitation of 
randomly agglomerated PEG-CNTs on the CNT-PA-L surface, resulting in 
nanostructured surface. In addition, the successful outcome of Col-I linkage on Col-
PA-L was verified by immunostaining with Col-I (Figure 5.1C).  
In this study, the hydrogels were tailored to mimic the stiffness of the normal human 
liver for effective hepatic differentiation of hAECs. AFM nanoindentation results 
showed that Col-PA-L and CNT-PA-L had Young’s modulus of 3.39±0.56 KPa and 
3.92±0.15 KPa, respectively (Figure 5.1D). The slight increase in CNT-PA-L stiffness 
could be attributed to the thin layer of PEG-CNT deposition. Anyway, both hydrogels 
achieved desired stiffness to mimic normal liver, whose stiffness should be kept lower 




Figure 5.1 Characterization of hydrogels. (A) Surface morphology of different 
hydrogels taken by microscope with bright field; (B) surface morphology of hydrogels 
observed by SEM; (C) fluorescent staining of Col-I on PA without (left)/with (right) 
the treatment of sulfo-SANPAH and subsequently incubated with Col-I to prepare Col-
PA-L; (D) stiffness (Young’s modulus) of hydrogels tested by AFM nanoindentation. 
The dotted horizontal line at Young’s modulus of 6 KPa, is a threshold of stiffness for 
a normal healthy liver. 
 
5.3.2 Cell morphology and viability 
Over the 18 days differentiation period, cells remained effectively attached on the 
matrix as shown in Figure 5.2. The hAECs and HLCs exhibited limited growth, 
regardless of the substrates (cover slips, Col-PA-L and CNT-PA-L) or culture media 
(growth medium and hepatic induction medium) they are incubated with. When 
subjected to hepatic induction, hAECs gradually acquired a polygonal and granular 
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morphology (similar to normal hepatocytes) from the fibroblastic bipolar morphology 
in a time-dependent manner.  
Using alamarBlue assay as a real-time indication of cell viability (Figure 5.3), hAECs 
and HLCs on various surface coating demonstrated slow growth and the cell number 
reached plateau around day 10, followed by a slight decrease. All the samples 
maintained comparable cell growth until day 13. Statistically significant difference was 
obtained (1) on day 15, when HLCs on cover slips had higher cell growth than the other 
three samples (P<0.01) and (2) on day 18 when HLCs on cover slips displayed higher 









Figure 5.3 Viability of hAECs and HLCs on various substrates across 18 days as 




In order to assess the commitment of the treated hAECs towards hepatogenesis, 
transcript levels of genes representative of stem cell pluripotency, liver development 
and hepatic functions were measured using RT-PCR at the end of the 18 days 
differentiation protocol. As shown in Figure 5.4, transcriptional levels of Nodal, Nanog 
and OCT4 in all HLCs groups were significantly decreased compared to the negative 
control (non-induced hAECs on cover slips) (P<0.05). This observation was 






Figure 5.4 Expression of pluripotent markers by hAECs, HLCs on different scaffolds, 
HepG2 and HepaRG cells by RT-PCR analysis, n=3. One-way ANOVA was used for 
statistical analysis, *=P<0.05. 
 
In terms of hepatocytic phenotype, compared to the negative control, the level of AFP 
expression was slightly higher in the HLCs on cover slips and Col-PA-L while the level 
was 20-fold higher in the HLCs on CNT-PA-L albeit no statistically significant 
difference was observed (Figure 5.5A). HepG2 cells expressed thousand-fold higher 
level of AFP, which was significantly higher than any other sample, including HepaRG 
(P<0.001). As for ALB (Figure 5.5B), hepatic induction condition failed to up-regulate 
its expression in HLCs on cover slips, but significantly improved ALB expression by 
3-fold on Col-PA-L (P<0.01) compared with the negative control. Moreover, the 
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expression of ALB in HLCs on CNT-PA-L was significantly elevated by 50-fold as 
compared to negative control and by 45-fold as compared to Col-PA-L (P<0.01). The 
expressed ALB levels in HepG2 and HepaRG cells were much higher than that in the 
hAEC-derived hepatocytes (P<0.05). Likewise, Figure 5.5C and D showed that the 
levels of HNF4α and α1AT marginally increased in HLCs on cover slips and Col-PA-
L. This level of induction was more pronounced in the case of CNT-PA-L as the scaffold 
in spite of non-significant difference compared to the negative control. Notably, the 
HNF4α level on CNT-PA-L was comparable with that of HepaRG cells. The mRNA 
expression level of glucose-6-phosphatase (G6P) was slightly up-regulated in HLCs on 
cover slips without any statistically significant difference to the negative control, 
whereas Col-PA-L boosted G6P expression in HLCs with significantly higher level in 
comparison with the negative control (Figure 5.5E). Compare to Col-PA-L, CNT-PA-
L significantly up-regulated G6P expression in HLCs (P<0.05), and the level was even 
significantly higher than that in HepG2 and HepaRG cells (P<0.05). Specifically, the 
HLCs on CNT-PA-L displayed 250-fold higher level of G6P than HepG2 and HepaRG 
cells. Again, the HLCs on CNT-PA-L exhibited the significantly higher level of CK18 
than the rest samples, including the positive controls (P<0.01, Figure 5.5F). Similarly, 
HLCs on CNT-PA-L gained significantly higher production levels of hepatic enzyme 
markers of CYP3A4 and CYP2C9 when compared to all the other samples (P<0.05, 
Figure 5.5G and H). These levels were even hundred times higher than that in HepG2 
and HepaRG cells. HLCs on Col-PA-L revealed the second highest expression level of 
CYP3A4 and CYP2C9, which was significantly higher than that in the negative control 
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(P<0.05). Again, the expression of CYP3A4 and CYP2C9 in HLCs on cover slips was 
slightly increased without any statistically significant difference compared to negative 
control.  
To sum up, RT-PCR results revealed an unequivocally higher expression levels of AFP, 
ALB, α1AT and HNF4α in HLCs on CNT-PA-L compared to negative control and 
HLCs on cover slips and Col-PA-L, although the levels were lower than that in HepG2 
or HepaRG cells. Moreover, the expression levels of other classical hepatocyte 
biomarkers such as CK18, G6P, CYP3A4 and CYP2C9 in HLCs on CNT-PA-L were 





Figure 5.5 Expression of hepatic markers including (A) AFP, (B) ALB, (C) HNF4α, (D) 
α1AT, (E) G6P, (F) CK18, (G) CYP3A4 and (H) CYP2C9 in hAECs, HLCs on different 
substrates, HepG2 and HepaRG cells by RT-PCR analysis, n=3. One-way ANOVA was 




The extent of hepatic differentiation of HLCs as observed from transcript analysis was 
further corroborated by immunofluorescence imaging of pluripotent and hepatic 
markers. DAPI staining indicate the presence of nuclei to help in enumeration of cells, 
while HepG2 cells were included as a positive control.  
Overall, weak OCT4 protein staining was seen in all samples. This result indicated 
pronounced loss of pluripotency in hAECs and HLCs, which was similar to HepG2 
cells (Figure 5.6A). Shown from Figure 5.6B, minimal AFP staining was observed in 
the hAECs and HLCs on cover slips. In contrast, there was a small fraction of HLCs 
positively stained on Col-PA-L, which was comparable with the staining in HepG2 
cells. As compared to the rest samples, a larger fraction of HLCs on CNT-PA-L was 
positive for AFP staining. Figure 5.6C illustrated strongly positive expression of ALB 
in HLCs on CNT-PA-L while the ALB staining in the rest samples, including HepG2 
cells, was negligible. Additionally, hAECs and HLCs on cover slips showed weakly 
positive staining of HNF4α protein. Relatively more HNF4α positive cells were 
obtained in HLCs on Col-PA-L and CNT-PA-L, while HepG2 cells possessed strongest 
staining of HNF4α protein which was localized to the nuclei (Figure 5.6D). The semi-
quantitative average fluorescence intensity of various proteins per cell area was shown 


























Figure 5.6 Immunostaining of hAECs, HLCs on various substrates and HepG2 cells at 
day 18 with (A) OCT4 (green), (B) AFP (green), (C) ALB (green), (D) HNF4α (green) 
and DAPI (blue), as well as (E) semi-quantitative average fluorescence intensity per 
cell area. 
 
5.3.5 Hepatic function studies 
5.3.5.1  ALB secretion 
To analyze classical hepatic function, the secretion of ALB from treated cells into 
culture medium was examined by ELISA. As shown from Figure 5.7, human specific 
ALB produced by HLCs on Col-PA-L and CNT-PA-L was detected in cell culture 
supernatant from day 3 onwards, whereas the cells grown on cover slips only showed 
ALB production from day 5. No secreted ALB was detected in the negative control 
(non-induced hAECs on cover slips) throughout the 18 days incubation (data not 
shown), indicating that ALB secretion was only acquired in the presence of hepatic 
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induction medium. For the rest of the samples, a progressive increase in ALB 
production was observed in all HLCs, confirming the commitment towards hepatocytic 
lineage. Generally speaking, there was no statistically significant difference between 
HLCs on various scaffolds, except on day 8 when HLCs grown on hydrogels released 
significantly larger amount of ALB than that on cover slips (P<0.05). The peak 
concentration of ALB from HLCs on cover slips, Col-PA-L and CNT-PA-L normalized 
by cell viability (alamarBlue intensity) were 3.99±0.30 (10-5ng/ml), 6.23±0.67 (10-
5ng/ml) and 5.74±0.90 (10-5ng/ml), respectively on day 18. The corresponding level of 
this activity in HepG2 cells was significantly higher than hAEC-derived hepatocytes 
(P<0.001) and reached 40.78±1.48 (10-5ng/ml). 
 
Figure 5.7 ALB secretion by HLCs on different scaffolds and HepG2 cells during the 
course of 18 days differentiation, n=3. One-way ANOVA was used for statistical 




5.3.5.2 ICG uptake and clearance 
The vital liver cell function of eliminating diverse compounds from the circulation 
involves an intricate balance of hepatocellular uptake, conjugation, and subsequent 
release of the compounds (213). ICG, used clinically for hepatic function test, is a non-
toxic organic anion that is exclusively taken into mature hepatocytes through an active 
uptake mechanism and subsequently released with time (214, 215). Hence, ICG uptake 
and elimination was used to identify differentiated hepatocytes in vitro.  
At the end of 18 days culturing, ICG-positive cells were detected in every sample after 
1 hour incubation with ICG (Figure 5.8). Comparing to the negative control which was 
only stained with a small amount of ICG, the capacity of ICG uptake in the HLCs on 
cover slips, Col-PA-L and CNT-PA-L was notably higher. HLCs on CNT-PA-L most 
effectively took up ICG with the largest amount of cells stained intensely in green color. 
This uptake ability of HLCs on CNT-PA-L was higher than that observed in HepG2 
cells.  
After incubation with ICG free culture medium for another 6 hours, all HLCs and 
HepG2 cells eliminated most of the dye from the cytoplasm. On the contrary, the 
negative control retained ICG intracellularly, indicating their initial uptake of ICG was 
via non-specific mechanisms and they lacked the molecular machinery to mediate its 
efflux. Therefore, only the HLCs on cover slips, Col-PA-L and CNT-PA-L as well as 
HepG2 cells demonstrated the capacity of mature hepatocytes with regard to uptake 
and excretion of ICG with time. Again, these results confirm the enhanced hepatic 








5.3.5.3 CYP3A4 activity 
Given a likely application of ex vivo cultured hepatocytes as diagnostic tools for 
evaluating drug toxicity, the key hepatic enzyme, CYP3A4, was monitored. We assayed 
the metabolism of Luciferin-IPA as a prototypical substrate for the enzyme. No 
functional CYP3A4 activity was detected in the negative control (hAECs on cover 
slips). The order of CYP3A4 activity found in the remaining samples was: HLCs on 
cover slips < HLCs on Col-PA-L < HLCs on CNT-PA-L < HepG2. (Figure 5.9). As 
another positive control, HepaRG cells exhibited 10 times higher CYP3A4 activity than 
HepG2 cells (data not shown in Figure 5.9 due in the insufficient replicates). 
 
 
Figure 5.9 CYP3A4 activity corrected against cell viability in HLCs on different 






5.3.5.4 CYP3A4 induction 
The hepatic CYP3A4 is uniquely regulated by PXR transcription factor which can be 
induced by a variety of drugs such as rifampin, leading to accelerated metabolism (216). 
Therefore, the ability of CYP3A4 induction by rifampicin was monitored to assess if 
the HLCs obtained the key attribute of hepatocytes. In the rifampicin-treated groups, 
no functional CYP3A4 activity was detected in the negative control, HLCs on cover 
slips and on Col-PA-L. The CYP3A4 function in HLCs on CNT-PA-L was induced by 
rifampicin to a similar extent as that in HepG2 cells (2-fold change) without statistically 
significant difference (Figure 5.10). On the other hand, the CYP3A4 activity in 
HepaRG cells were highly induced with around 70-fold change (data not shown in 
Figure 5.10 due to insufficient replicates). The results of CYP3A4 and induced 
CYP3A4 activities (Figure 5.9 and 5.10) were in accordance with the former findings 
that HepaRG cells generate improved hepatic functions including major CYP enzymes 
involved in drug metabolism compared to HepG2, which is a hepatoblastoma cell line 





Figure 5.10 Induction of CYP3A4 enzyme activity by rifampicin in HLCs on CNT-PA-
L and HepG2 cells, n=3. The two-tailed unpaired student’s t test was used for statistical 
analysis. 
 
Together, this study firstly confirmed the successful preparation of CNT-PA-L matrix 
with a customized stiffness mimicking that of a normal liver. Secondly, when treated 
with hepatic differentiation medium, hAECs on cover slips partially differentiated into 
HLCs by losing their stem cell phenotype and acquiring a hepatocytic phenotype in 
terms of cell morphology, mRNA signature, protein expression and functional 
characteristics. Thirdly, compared to cover slips, Col-PA-L enhanced the hepatic 
differentiation of hAECs with better performance in up-regulating hepatic genes and 
protein expression as well as hepatic function. Lastly, CNT-PA-L were superior to 
existing matrix (cover slips and Col-PA) in coaxing hAECs towards mature hepatocytes, 
shown by higher expression of several hepatic markers, higher ICG uptake and 
comparable CYP3A4 enzymatic function and CYP3A4 induction activity in 
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comparison with HepG2 cells. Table 5.2 summarized the observation of the 
characteristics of hAECs, HLCs on various substrates, HepG2 and HepaRG cells. 
 
Table 5.2 Summary of characteristics of hAECs, HLCs on various substrates, HepG2 














Nodal Control ↓ ↓ ↓ ↓↓ ↓↓ 
Nanog Control ↓ ↓ ↓ ↓↓ ↓↓ 
OCT4 Control ↓ ↓ ↓ ↓↓ ↓↓ 
Pluripotent 
protein 
OCT4 Control ~ ~ ~ ~ NA 
Hepatic  
genes 
AFP Control ↑ ↑ ↑↑ ↑↑↑↑ ↓ 
ALB Control ~ ↑ ↑↑ ↑↑↑↑ ↑↑↑↑ 
HNF4α Control ↑ ↑ ↑↑ ↑↑↑ ↑↑ 
α1AT Control ↑ ↑ ↑ ↑↑↑ ↑↑↑↑ 
G6P Control ↑ ↑↑ ↑↑↑ ~ ↓ 
CK18 Control ↓ ~ ↑ ↓ ↓↓ 
CYP3A4 Control ↑ ↑ ↑↑↑ ↓ ↑ 
CYP2C9 Control ↑ ↑↑ ↑↑↑ ↓ ↑ 
Hepatic 
proteins 
AFP Control ~ ↑ ↑↑ ↑ NA 
ALB Control ~ ~ ↓ ~ NA 
HNF4α Control ↓ ↑ ↑ ↑↑ NA 
Hepatic 
functions 
ALB secretion NA ↑ ↑↑ ↑↑ ↑↑↑ NA 
ICG uptake Control ↑ ↑ ↑↑ ↑ NA 
CYP3A4 
activity 
NA ↑ ↑ ↑ ↑ ↑↑ 
CYP3A4 
induction 
NA NA NA ↑ ↑ ↑↑ 
↓=decreased, ↑=increased, ~=no change, NA=not applicable 
 
5.4 Discussion 
In this study, we explored CNT-PA-L influence on hepatic differentiation of hAECs, 
with the aim to maximize the potential of this readily available stem cell type. Critical 
to our hypothesis was that (1) PA could tailor the matrix stiffness close to that of a 
normal human liver; (2) PEG-CNTs as a coating material resulted in a nanostructure 
surface, which mimicked the native ECM in liver. When put together, the crux of our 
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findings was that CNT-PA-L worked as a remarkable scaffold that not only preserved 
the viability of the hAECs adhered to its surface, but also further enhanced the 
differentiation of hAECs to functional HLCs compared to cover slips and Col-PA-L.  
Viability of all the cells was found to be good with progressive but limited growth 
observed over the 18 days incubation (Figure 5.3). While hAECs on cover slips initially 
exhibited great growth potential (until day 10), HLCs (which were incubated in hepatic 
medium on cover slips) had significantly higher cell growth than hAECs on day 15 
(P<0.01) and day 18 (P<0.001). It is plausible that the stimulants for higher viability 
with prolonged incubation were likely the growth factors contained within the hepatic 
medium. It was reported that the hepatic inducing medium consisting of HGF and FGF 
promoted both growth and hepatic differentiation of adipose-derived stem cells (218). 
However, the focal point of interest is the differential effect of matrix, where cell 
viability on CNT-PA-L was the lowest among the three platforms on day 15 and day 18 
(P<0.01 compared to HLCs on cover slips). In the absence of overt cytotoxicity as a 
cause of reduced viability (Figure 5.2), we speculate this to be an outcome of a trade-
off between cell differentiation and growth, a phenomenon extensively reported and 
widely accepted (163, 164). In other words, the stimuli provided by the CNT-PA-L had 
committed the HLCs towards differentiation at the expense of some growth. This will 
be a point of evaluation for the subsequent experiments. 
Accordingly, transcript profiling and immunostaining were conducted to gain insights 
into the spectrum of stem cell and liver signature markers at the end of the 
differentiation protocol. hAECs were reported to express OCT4 and Nanog, genes 
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known to be required for self-renewal and pluripotency (202, 219). The reduced 
expression of these genes characterized loss of pluripotency and early differentiation 
of HLCs (Figure 5.4 and 5.6, Table 5.2). 
The hepatic markers evaluated in this study represented an attempt to capture the 
distinctive clinical functions of the liver, and also to identify the different stages during 
liver development. To facilitate this discussion and substantiate our hypothesis, a 
summary of the justification of the chosen markers is provided in the Table 5.3. 
Collectively, the increased expression of ALB, HNF4α, α1AT and CK18 supported that 
the HLCs subjected to different matrices were committed to hepatocyte differentiation. 
The elevation of AFP indicated a fetal liver characteristic, whereas the up-regulation of 
G6P, CYP3A4 and CYP2C9 suggested that the HLCs were more like mature 
hepatocytes.  
Importantly, at both transcript and protein levels, CNT-PA-L demonstrated superior 
expression of all hepatic markers in HLCs compared with other matrices such as cover 
slips and Col-PA-L (Figure 5.5 and 5.6, Table 5.2). Moreover, CNT-PA-L coaxed these 
HLCs towards higher hepatic functions such as secretion of ALB, uptake and clearance 
of ICG, CYP3A4 and inducible CYP3A4 activities (Table 5.2). These demonstrable 
hepatic functions corroborated the findings obtained from transcript and protein up-
regulation. Comparatively, the presence of Col-I in the matrix only supported hepatic 
differentiation of hAECs to limited extents with partial acquisition of hepatic markers 
and functions although Col-PA-L displayed better performance in the aspects of hepatic 
gene and protein expression as well as CYP3A4 activity than cover slips. Therefore, 
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the presence of PEG-CNTs enhanced the hepatic differentiation of hAECs vs. other 
well established matrices.  
 
Table 5.3 Justification of the selection of gene and protein markers characterized in this 
study 
Markers Remarks 
AFP AFP, thought to be the fetal form of serum ALB, is a major plasma protein 
produced by the fetal liver. AFP possesses transport function by binding heavy 
metals, fatty acids, various organic drugs and other agents (220). It is also 
proposed that AFP is involved in the control of proliferation, embryonic 
differentiation, regulation of osmotic pressure, protection of developing fetus 
from maternal immune system (220, 221). After birth the AFP level decrease 
rapidly and thus AFP is used as a fetal liver marker. AFP expression in adults is 
often associated with hepatoma or teratoma (222), explaining why HepG2 cells 
expressed thousand-fold higher level of AFP compared to the negative control 
(Figure 5.8). 
ALB ALB, the most abundant blood plasma protein, is initially expressed in early fetal 
liver cells and reach the maximal level in functional adult hepatocytes (223, 224). 
It is essential for maintaining the osmotic pressure of blood and also acts as a 
plasma carrier and transport proteins. The extent of albumin biosynthesis reflects 
the intrinsic function of the liver. 
HNF4α HNF4α was demonstrated crucial for specification of human hepatic progenitor 
cells from pluripotent stem cells by establishing the expression of a network of 
transcriptional factors that controls the onset of hepatocyte cell fate (225, 226). 
α1AT α1AT, produced predominantly by hepatocytes, is a serum protease inhibitor. Its 
major physiological function is inhibition of the destructive neutrophil proteases 
elastase, cathepsin G, and proteinase (204, 227, 228). 
CK18 The putative functions of cytokeratin in hepatocytes include cellular structure 
and integrity support, uptake and secretion of dyes and protein (229). The 
cytokeratin intermediate filament cytoskeleton of normal adult hepatocytes is 
composed of only CK8 and CK18 (229, 230). CK18 is weakly expressed in 
human hepatoblasts from the 4th week of gestation and continues to be expressed 
until mature hepatocytes (231). 
G6P In liver, G6P catalyzes the terminal step of glycogenolysis and gluconeogenesis 
for the production of glucose to release into blood (232). Hepatic G6P appears in 






Table 5.3 Justification of the selection of gene and protein markers characterized in 
this study (continued) 
CYP3A4 
CYP enzymes are essential for the metabolism of many medicines and 
endogenous compounds. CYP3A4 is the most abundant of all CYP enzymes in 
the liver and it is known to be involved in the metabolism of nearly 50% of all 
the drugs currently prescribed. CYP3A4 contributes to bile acid detoxification, 
the termination of action of steroid hormones, and elimination of 
phytochemicals in food and the majority of medicines (234, 235). Expression of 
this enzyme seems to be a key predictor of drug responsiveness and toxicity 
(236). CYP3A4 activity is absent in newborns but reaches adult levels at around 
one year of age (237). Therefore, it is a mature marker in hepatic development. 
CYP2C9 
CYP2C9 is primarily expressed in the liver, and the expression level is the 
second highest among CYP isoforms (238). It has been estimated that CYP2C9 
is responsible for the metabolic clearance of up to 15-20% of all drugs 
undergoing phase I metabolism (239). Similar to CYP3A4, the level of CYP2C9 
activity is very low during fetal development and increases dramatically during 
the first year of life after birth (240-242). 
 
Central to our innovation is the customization of the stiffness of the PEG-CNT matrix. 
PA as a basement allowed us to manipulate the stiffness of the thin PEG-CNT layer 
without confounding cell signaling via direct cellular contact. The reported Young’s 
modulus of human healthy liver was below 6 KPa (209, 210), whereas a dysfunctional 
liver can stiffen to 20 KPa or higher as fibrosis and cirrhosis develop (243). Increased 
stiffness of the ECM could be both a passive pathological process and an initiating 
factor for the development of liver carcinoma (244). It has been shown that the matrix 
stiffness can broadly impact the in vitro behaviors of hepatocytes. For example, 
compared to stiffer heparin gels (Young’s modulus, 116 KPa), the softer heparin gels 
(11 KPa) promoted better maintenance of the hepatic phenotype in primary rat 
hepatocytes with higher ALB secretion and stronger immunostaining of ALB and E-
cadherin (245). For these reasons, by setting the stiffness lower than 6 KPa, Col-PA-L 
and CNT-PA-L approximated the mechanical property of the normal liver and were 
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observed to enhance the hepatic differentiation of hAECs compared to cover slips. 
Collagen is the most widely used ECM protein for cell culture in facilitating cell 
attachment, growth, differentiation, migration, and tissue morphogenesis. Col-I coated 
matrix (Col-PA-L), therefore, was used in this study to compare the effect of PEG-
CNT coating in hAEC differentiation in to HLCs. Throughout all the investigation 
(acquisition of hepatic markers and function), CNT-PA-L were superior to Col-PA-L in 
coaxing hAECs towards mature hepatocytes (Table 5.2). This set of results followed a 
range of studies regarding nanomaterial-based scaffolds which have been already 
shown to boost the hepatic differentiation of various stem cells. For instance, when 
compare to substrata including Col-I, Matrigel, gelatin and fibronectin, all of which are 
commonly used to resemble the complex ECM, the hepatic differentiation of murine 
embryonic stem cells (mESCs) grown on a commercial nanofiber matrices were more 
dedicated into hepatic differentiation (246). Additionally, comparing to plain culture 
plate, a nanofiber scaffold composed of poly-L-lactic acid (PLLA) and collagen was 
shown to enhance hepatic differentiation of hMSCs (247) while a poly-amide nanofiber 
scaffold enhanced the hepatic differentiation of mMSCs (248) and hESCs (249). The 
enhanced hepatic differentiation was symbolized by up-regulation of hepatic markers 
(e.g., ALB, HNF4α and AFP) and increased hepatic functions like ALB secretion, ICG 
uptake and metabolic activity of the CYP enzymes. These observations imply that 
compared to Col-PA-L, CNT-PA-L possess the PEG-CNTs on surface and gain the 
potency to mimic the nanostructure in basement membrane substratum of the liver cells 
(46, 49), thus better facilitating the hAECs to differentiate into HLCs. Therefore, both 
116 
 
liver stiffness-mimicking PA and PEG-CNT coating in CNT-PA-L can synergistically 
instruct the enhanced differentiation of the hAECs into functional HLCs. 
Previous reports described insufficient in vitro hepatic differentiation of hAECs, where 
the generated HLCs were more fetal-like rather than functional adult hepatocytes. For 
example, the HLCs from hAECs on culture plates possessed low transcript levels of 
hepatic markers, as the increase in hepatic genes was not higher than 5-fold compared 
to hAECs (45). Additionally, the HLCs from hAECs cultured on porcine liver-derived 
ECM metabolized drugs in a manner similar to fetal human hepatocytes (207). The 
encapsulated HLCs from hAECs in barium alginate microspheres were found to be 
functionally close to HepG2 cells in terms of induced CYP3A4 activity and urea 
synthesis (44). However, conditioned medium from HepG2 cells with potential 
problems in clinical application, was used in this study for hepatic differentiation of 
hAECs. Comparing to these reports, HLCs on CNT-PA-L in our study were more 
mature HLCs with high expression of hepatic genes and proteins, as well as adequately 
hepatic functions although they preserved fetal-liver property like AFP expression. 
Specifically, the transcript levels of G6P, CK18, CYP3A4 and CYP2C9, protein 
expression of AFP and ALB, as well as ICG uptake in HLCs on CNT-PA-L were even 
higher than that in the positive control (i.e., HepG2 or HepaRG cells). Moreover, 
CYP3A4 activity and fold change of CYP3A4 activity with rifampicin induction in the 
HLCs on CNT-PA-L were comparable to that of HepG2 cells. Taken together, these 
observations revealed that the CNT-PA-L is a conducive matrix to enhance the extent 
of hepatic differentiation of hAECs into functional HLCs. As far as we know, this is 
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the first reported study of in vitro stem cell-derived hepatocytes on CNT-based 
scaffolds. 
At this stage, there remains additional characterization to ascertain if such 
differentiated HLCs are really capable of reproducing functions that are comparable 
with normal adult hepatocytes for the specific application intended. Critical hepatocytic 
functions such as clotting factor biosynthesis, metabolism of ammonia and bilirubin, 
as well as handling of xenobiotics by more Phase I and II enzymes should be 
established as part of the evaluation of cell maturity (34). Therefore, the functional 




5.5 Chapter conclusion 
In this study, liver-stiffness mimicked Col-PA-L and CNT-PA-L was developed and 
well supported hAEC attachment, growth and hepatic differentiation. Functional HLCs 
derived from hAECs lost their stem cell characteristics and switched to increased 
expression of hepatocyte specific markers, transcription factors and functional enzymes. 
Moreover, HLCs demonstrated the functional capabilities of hepatocytes such as ALB 
secretion, uptake and clearance of ICG, CYP3A4 function and inducible CYP3A4 
activities. HLCs on CNT-PA-L showed enhanced hepatic induction and were more like 
the functional hepatocytes compared with that on cover slips and Col-PA-L (Figure 
5.11). The use of functional hepatocytes derived from hAECs may circumvent the 
scarcity of liver donors and offer a promising source of hepatocytes for cell therapy 
and tissue engineering in future. More importantly for the interest of this thesis, this 
work enabled us to push the limits of PEG-CNTs as a versatile material to support the 
maintenance and differentiation of stem cells beyond those of mesenchymal origin. 
 
 
Figure 5.11 A conclusion figure for Chapter 5: CNT-PA-L enhanced the hepatic 






CHAPTER 6.  Conclusion and future perspectives 
6.1 Overall conclusion 
In Chapter 1, the combination of carbon nanotube (CNT)-based scaffolds and stem 
cells was discussed as a versatile strategy in tissue engineering. Subsequently, Chapter 
2 indicated that aim of this thesis was to evaluate the versatility of polyethylene glycol-
linked multi-walled carbon nanotubes (PEG-CNTs) as a coating material in enhancing 
the course of stem cell differentiation towards dedicated lineages under suitable 
conditions, specifically in skeletal muscle engineering and liver engineering. 
In Chapter 3, we reported the fabrication and characterization of PEG-CNT films to 
support the growth and spontaneous skeletal myogenic differentiation of human 
mesenchymal stem cells (hMSCs). The PEG-CNT films (coated on cover slips) of 
around 5 μm thickness were successfully prepared with nanorange surface roughness, 
orderly arrangement of PEG-CNTs, high hydrophilicity and high mechanical strength. 
Cell viability staining and quantification demonstrated that PEG-CNT films well 
supported cellular adhesion and growth of hMSCs. The highlight of this study was that 
PEG-CNT films alone could direct the skeletal myogenic differentiation of hMSCs in 
the absence of myogenic inducing factors. Quantitative real-time polymerase chain 
reaction (RT-PCR) showed that the non-induced hMSCs plated on PEG-CNT films, 
compared to the negative control, presented higher levels of myogenic markers 
including early commitment markers of myoblast differentiation protein-1 (MyoD) and 
desmin, late phase marker of myosin heavy chain (MHC), as well as higher level of the 
skeletal muscle-specific marker, fast skeletal troponin-C (TnC) and ryanodine receptor 
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1 (Ryr). Moreover, the levels of these myogenic markers were higher than 
myogenically-induced hMSCs plated on cover slips and comparable with 
myogenically-induced hMSCs plated on PEG-CNT films. Corresponding protein 
analysis by immunoblot assays corroborated the RT-PCR results by detection of 
stronger expression of myogenic proteins in terms of MyoD, desmin and MHC in all 
hMSCs plated on PEG-CNT films. The commitment of non-induced hMSCs plated on 
PEG-CNT films to specific skeletal myocytes was further substantiated by the absence 
of enhanced adipogenic, chondrogenic and osteogenic markers. These findings 
strengthened the distinctive role of PEG-CNTs in the differentiation process that is non-
replaceable by myogenic induction. 
To optimize the physical characteristics of the PEG-CNT-based scaffold, we explored 
the role of matrix stiffness in myogenic differentiation of hMSCs in Chapter 4. Therein, 
we successfully designed, fabricated and characterized PEG-CNTs coated poly-
acrylamide hydrogel (PA) with stiffness close to muscle (CNT-PA-M). Moreover, we 
demonstrated spontaneous myogenesis of hMSCs on CNT-PA-M and collagen-I coated 
PA with mimicked muscle stiffness (Col-PA-M). This study indicated new 
opportunities to fine-tune scaffolds in support of different types of stem cell 
differentiation.  
We, therefore, presented a customized PEG-CNTs coated PA with mimicked liver 
stiffness (CNT-PA-L) to enhance hepatic differentiation of a different stem cell source, 
human amniotic epithelial cells (hAECs) in Chapter 5. The CNT-PA-L well supported 
the attachment and growth of hAECs. For the hepatic differentiation, hepatocyte-like 
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cells (HLCs) derived from hAECs lost their stem cell characteristics and switched to 
increased expression of hepatocyte specific markers, transcription factors and 
functional enzymes, demonstrated by RT-PCR and immunostaining assays. Moreover, 
HLCs demonstrated the functional capabilities of hepatocytes such as albumin (ALB) 
secretion, uptake and clearance of indocyanine green (ICG), CYP3A4 function and 
inducible CYP3A4 activities. Overall, we gathered evidence that HLCs on CNT-PA-L 
showed enhanced hepatic induction and resembled functional hepatocytes more closely 
than that on cover slips and collagen-1 coated PA with mimicked liver stiffness (Col-
PA-L).  
As we now conclude in Figure 6.1, PEG-CNTs work well as a versatile coating material 
that can maintain the ex vivo expansion of various stem cell types (e.g., hMSC or 
hAECs) and also coax them into differentiation with/without the influence of 
differentiation induction factors in our studies. Importantly, these findings offer an 
important tool of the combination of stem cells and PEG-CNT-based scaffolds in tissue 





Figure 6.1 PEG-CNTs worked as a versatile coating material to coax different stem cells 
to differentiate into various lineages. 
 
6.2 Future perspectives 
Our current findings open new research opportunities and knowledge along a number 
of well-defined tangents. The specific future work was proposed in the discussion or 
conclusion sections of each chapter. Here we broadly discuss the future direction of 
PEG-CNT-based scaffold design and preparation for optimizing stem cell 
differentiation with promoted tissue-specific characteristics. 
 
6.2.1 Aligned PEG-CNTs coated PA   
Cells in tissues are arranged in distinct patterns. The orientation and the position of the 
cells with respect to each other are dictated by the tissue type (250). For instance, the 
skeletal muscle tissues are predominantly composed of bundles of highly oriented and 
dense muscle fibers, each comprising a multinucleated cell derived from myoblasts 
(137). In other words, skeletal muscle is composed of many muscle cells that are 
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aligned with one another. Meanwhile, the liver is organized into lobules which are 
typically hexagonal in cross section. These lobules comprise of rows of hepatocytes 
which orderly radiate out from a central vein.  
Various studies proved that cells are affected by the topography of the surface on which 
they were seeded. The growth and differentiation of stem cells could also be guided by 
the orientation of the individual nanomaterials within the bulk matrix. Wang and 
colleagues demonstrated that neural progenitor cells (NPCs) could recognize the 
arrangement of collagen nanofibers and grew more efficiently on the aligned 
nanofibers than on substrates with random orientation (251). Likewise, compared with 
the random array of nanomaterials, the aligned poly-L-lactic acid (PLLA) nanofibers 
could enhance the differentiation of bone marrow stromal cells into osteocytes (252); 
aligned poly-caprolactone (PCL)/PLLA/nano-hydroxyapatite (HA) scaffolds increased 
the differentiation of human unrestricted somatic stem cells (USSCs) into bone cells 
(60), and the aligned CNTs exhibited enhanced proliferation and osteogenic 
differentiation of hMSCs (75). A possible explanation for the enhanced proliferation 
and differentiation of stem cells might be that ordered nanomaterials better mimic the 
orderly pattern of natural extracellular matrix (ECM) in which the fibers/fibrils are 
parallel to each other and form an arranged field to support cells (251). 
To mimic the ECM arrangement in the muscle and liver, the next phase of scaffold 
development could involve aligned PEG-CNTs coated PA (A-CNT-PA) as a promising 
advancement. As a preliminary attempt at this, an electrophoretic deposition method 
was used for PEG-CNT alignment. We designed and fabricated an alignment setup into 
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a commercial optical microscope (Figure 6.2A). This design is an in situ observation 
and control on the PEG-CNT alignment. Figure 6.2B shows the real apparatus and 
Figure 6.2C is the design plot. This setup, easy to assemble and disassemble, is 
composed of two electrodes between which the distance is 1 cm, two magnets and a 
Teflon base. In the process of electrophoretic deposition, PEG-CNT water suspension 
(200 μg/ml) was loaded onto the dried glass (1 cm X 1 cm, connected to the electrodes). 
With the electric (alternating current, AC, 200 V, 50 Hz) and magnetic fields, the PEG-
CNTs can be rotated and align along the direction of the electric field. The magnetic 
field introduces external Lorentz force on PEG-CNTs for vibrating and thus good 
dispersion of individual PEG-CNT can be achieved. Because of the structure of PEG-
CNTs, the dipole moment in the direction parallel to the tube axis is significantly 
stronger than that in the perpendicular direction. Therefore, PEG-CNTs could be 
aligned along the direction of the electric field (253). After evaporation of water, 





Figure 6.2 (A) A photo of the in situ observation setup for PEG-CNT alignment; (B) 
different components of the setup; (C) a design plot to show the electrical (AC) and 
magnetic field. 
 
The muscle stiffness mimicked A-CNT-PA (A-CNT-PA-M) and liver stiffness 
mimicked A-CNT-PA (A-CNT-PA-L) were prepared according to the methods in 
Chapter 4 (section 4.2.1, page 56) and Chapter 5 (section 5.2, page 75), respectively, 
but with one of the cover slips changed into the aligned PEG-CNT deposited glass. The 
aligned PEG-CNTs can be easily transferred onto the PA and the stiffness difference 
did not affect the scaffold fabrication and surface properties (Figure 6.3B and C). SEM 
observation showed higher magnification images of the A-CNT-PA-M and A-CNT-PA-
L (Figure 6.3 C), indicating that the alignment of PEG-CNTs only existed in 
microrange, not in nanoscale. Since the cell size is in microrange, cell culturing was 






Figure 6.3 Morphology of the aligned PEG-CNTs coated surfaces. (A) Aligned PEG-
CNTs coated glass; (B) optical microscope observation of A-CNT-PA-M and A-CNT-





Non-induced hMSCs and hAECs were cultured on A-CNT-PA-M and A-CNT-PA-L in 
maintenance medium, respectively. The cell culturing methods were shown in Chapter 
3 (section 3.2.3, page 25) and Chapter 5 (section 5.2.3, page 76), respectively. 
Unfortunately, neither hMSCs nor hAECs could attach onto the scaffolds (Figure 6.4). 
This may be because PA does not readily adsorb proteins, and thus it is essential to coat 
the hydrogel with PEG-CNTs to ensure efficient cell attachment (254). However, the 
gap between aligned PEG-CNT bundles may be too wide to support cell attachment. 
Therefore, denser aligned PEG-CNT bundles can be developed in future for desired 
cell adherence. This may be achieved by increasing the electric filed intensity or AC 





Figure 6.4 (A) hMSCs cultured on A-CNT-PA-M across 21 days; (B) hAECs 




6.2.2 PEG-CNT-based 3D scaffold 
Nowadays, an increasing number of researchers have questioned the validity of 
studying cells in two dimensional (2D) environment because all the tissues and organs, 
such as muscle and liver, are comprised of three dimensional (3D) arranged cells (46, 
137). 2D culture surface is not physiological for cells and induced cells to lose their 
native characteristics and display vast difference to their in vivo counterparts. These 
drawbacks of 2D culture systems can cause alterations in cell morphology, metabolism, 
gene expression patterns and cellular signaling, which may compromise cellular 
functions (255-258). As such, 2D substrates are significantly limited in reproducing the 
complex cellular environment in the muscle and liver. 
The benefits of 3D scaffolds in skeletal muscle engineering and liver engineering were 
shown in previous studies. For example, murine myoblasts (C2C12) seeded 3D 
collagen composite scaffolds were implanted into the defect sites in the mice skeletal 
muscle and the muscle healing was improved by an increased quantity of innervated 
and vascularized regenerated muscle fibers (128). In another study, the differentiating 
potential of human embryonic stem cells (hESCs) into hepatocytes on 2D collagen 
coated dishes and in 3D collagen scaffold culture systems was examined with 
exogenous growth factors to induce hepatic histogenesis (215). Although the 
differentiated cells in 2D and 3D culture system displayed several characteristics of 
hepatocytes [including expression of transthyretin, α-1-antitrypsin (α1AT), cytokeratin 
8, 18, 19, tryptophan-2, 3-dioxygenase, tyrosine aminotransferase, glucose-6-
phosphatase (G6P), production of alpha-fetoprotein (AFP), ALB and urea], ALB and 
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G6P were detected earlier and higher levels of urea and AFP were produced in 3D 
culture compared with 2D culture. Therefore, to further explore PEG-CNT applications 
in tissue engineering, a 3D scaffold with PEG-CNTs coated surface can be developed.  
 
Beside the merits in muscle and liver engineering studied in this thesis, the combination 
of stem cells and PEG-CNT-based scaffolds can also be explored in other areas such as 
kidney, nerve, lung or skin in future. Based on the promising results obtained in this 
thesis, it is expected that such combination strategy will develop into an important tool 
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